<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables v1.3 20210610//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-3.dtd?><?SourceDTD.Version 1.3?><?ConverterInfo.XSLTName jats-oasis2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">mBio</journal-id><journal-id journal-id-type="iso-abbrev">mBio</journal-id><journal-id journal-id-type="publisher-id">mbio</journal-id><journal-title-group><journal-title>mBio</journal-title></journal-title-group><issn pub-type="epub">2150-7511</issn><publisher><publisher-name>American Society for Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmcid">11253638</article-id><article-id pub-id-type="pmid">38860787</article-id>
<article-id pub-id-type="publisher-id">01351-24</article-id><article-id pub-id-type="doi">10.1128/mbio.01351-24</article-id><article-id pub-id-type="publisher-id">mbio.01351-24</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="biological-terms"><compound-subject><compound-subject-part content-type="code">plant-microbiology</compound-subject-part><compound-subject-part content-type="label">Plant Microbiology</compound-subject-part></compound-subject></subj-group></article-categories><title-group><article-title>Edeine B<sub>1</sub> produced by <italic toggle="yes">Brevibacillus brevis</italic> reduces the virulence of a plant pathogenic fungus by inhibiting mitochondrial respiration</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Bomin</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role></contrib><contrib contrib-type="author"><name><surname>Nguyen</surname><given-names>Minh Van</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Jiyeun</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Yeong Seok</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role></contrib><contrib contrib-type="author"><name><surname>Han</surname><given-names>Jae Woo</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Joo-Youn</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0617-4007</contrib-id><name><surname>Jeon</surname><given-names>Junhyun</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5080-7951</contrib-id><name><surname>Son</surname><given-names>Hokyoung</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Gyung Ja</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6727-4469</contrib-id><name><surname>Kim</surname><given-names>Hun</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cor1" ref-type="corresp"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role><email>hunkim@krict.re.kr</email></contrib><aff id="aff1"><label>1</label><institution-wrap><institution>Center for Eco-friendly New Materials, Korea Research Institute of Chemical Technology</institution></institution-wrap>, <city>Daejeon</city>, <country>South Korea</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution>Department of Medicinal Chemistry and Pharmacology, University of Science and Technology</institution></institution-wrap>, <city>Daejeon</city>, <country>South Korea</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution>Department of Agricultural Biotechnology, Seoul National University</institution></institution-wrap>, <city>Seoul</city>, <country>South Korea</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution>Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology</institution></institution-wrap>, <city>Daejeon</city>, <country>South Korea</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution>Department of Biotechnology, Yeungnam University</institution></institution-wrap>, <city>Gyeongsan</city>, <country>South Korea</country></aff></contrib-group><contrib-group><contrib contrib-type="editor"><role>Editor</role><name><surname>Vidaver</surname><given-names>Anne K.</given-names></name><aff><institution-wrap><institution>University of Nebraska&#x02013;Lincoln</institution></institution-wrap>, <city>Lincoln</city>, <state>Nebraska</state>, <country>USA</country></aff></contrib></contrib-group><author-notes><corresp id="cor1">Address correspondence to Hun Kim, <email xlink:href="mailto:hunkim@krict.re.kr">hunkim@krict.re.kr</email></corresp><fn fn-type="COI-statement"><p>The authors declare no conflict of interest.</p></fn></author-notes><pub-date publication-format="electronic" date-type="collection"><month>7</month><year>2024</year></pub-date><pub-date date-type="pub" publication-format="electronic"><day>11</day><month>6</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>11</day><month>6</month><year>2024</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>15</volume><issue>7</issue><elocation-id>e01351-24</elocation-id><history>
<date date-type="received"><day>03</day><month>5</month><year>2024</year></date>
<date date-type="accepted"><day>06</day><month>5</month><year>2024</year></date>
</history><permissions><copyright-statement>Copyright &#x000a9; 2024 Kim et al.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Kim et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2024-06-11"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="mbio.01351-24.pdf"/><abstract abstract-type="primary"><title>ABSTRACT</title><p>Plant pathogenic fungi cause serious diseases, which result in the loss of crop yields and reduce the quality of crops worldwide. To counteract the escalating risks of chemical fungicides, interest in biological control agents to manage plant diseases has significantly increased. In this study, we comprehensively screened microbial culture filtrates using a yeast screening system to find microbes exhibiting respiratory inhibition activity. Consequently, we found a soil-borne microbe <italic toggle="yes">Brevibacillus brevis</italic> HK544 strain exhibiting a respiration inhibitory activity and identified edeine B<sub>1</sub> (EB<sub>1</sub>) from the culture filtrate of HK544 as the active compound of the respiration inhibition activity. Furthermore, against a plant pathogenic fungus <italic toggle="yes">Fusarium graminearum</italic>, our results showed that EB<sub>1</sub> has effects on multiple aspects of respiration with the downregulation of most of the mitochondrial-related genes based on transcriptome analysis, differential EB<sub>1</sub>-sensitivity from targeted mutagenesis, and the synergistic effects of EB<sub>1</sub> with electron transport chain complex inhibitors. With the promising plant disease control efficacy of <italic toggle="yes">B. brevis</italic> HK544 producing EB<sub>1</sub>, our results suggest that <italic toggle="yes">B. brevis</italic> HK544 has potential as a biocontrol agent for Fusarium head blight.</p><sec><title>IMPORTANCE</title><p>As a necrotrophic fungus, <italic toggle="yes">Fusarium graminearum</italic> is a highly destructive pathogen causing severe diseases in cereal crops and mycotoxin contamination in grains. Although chemical control is considered the primary approach to control plant disease caused by <italic toggle="yes">F. graminearum</italic>, fungicide-resistant strains have been detected in the field after long-term continuous application of fungicides. Moreover, applying chemical fungicides that trigger mycotoxin biosynthesis is a great concern for many researchers. Biocontrol of <italic toggle="yes">Fusarium</italic> head blight (FHB) by biological control agents (BCAs) represents an alternative approach and could be used as part of the integrated management of FHB and mycotoxin production. The most extensive studies on bacterial BCAs-fungal communications in agroecosystems have focused on antibiosis. Although many BCAs in agricultural ecology have already been used for fungal disease control, the molecular mechanisms of antibiotics produced by BCAs remain to be elucidated. Here, we found a potential BCA (<italic toggle="yes">Brevibacillus brevis</italic> HK544) with a strong antifungal activity based on the respiration inhibition activity with its active compound edeine B<sub>1</sub> (EB<sub>1</sub>). Furthermore, our results showed that EB<sub>1</sub> secreted by HK544 suppresses the expression of the mitochondria-related genes of <italic toggle="yes">F. graminearum</italic>, subsequently suppressing fungal development and the virulence of <italic toggle="yes">F. graminearum</italic>. In addition, EB<sub>1</sub> exhibited a synergism with complex I inhibitors such as rotenone and fenazaquin. Our work extends our understanding of how <italic toggle="yes">B. brevis</italic> HK544 exhibits antifungal activity and suggests that the <italic toggle="yes">B. brevis</italic> HK544 strain could be a valuable source for developing new crop protectants to control <italic toggle="yes">F. graminearum</italic>.</p></sec></abstract><kwd-group><title>KEYWORDS</title><kwd><italic toggle="yes">Brevibacillus brevis</italic></kwd><kwd>respiratory inhibition</kwd><kwd>biocontrol</kwd><kwd>antifungal activity</kwd><kwd><italic toggle="yes">Fusarium graminearum</italic></kwd></kwd-group><funding-group specific-use="FundRef"><award-group award-type="grant" id="award-1"><funding-source>
<institution-wrap><institution>Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (iPET)</institution></institution-wrap>
</funding-source><award-id>321101-03</award-id><principal-award-recipient>
<name><surname>Kim</surname><given-names>Hun</given-names></name>
</principal-award-recipient></award-group><award-group award-type="grant" id="award-2"><funding-source>
<institution-wrap><institution>National Research Foundation of Korea (NRF)</institution></institution-wrap>
</funding-source><award-id>NRF-2019R1A2C1008103</award-id><principal-award-recipient>
<name><surname>Kim</surname><given-names>Hun</given-names></name>
</principal-award-recipient></award-group></funding-group><counts><count count="1" count-type="supplementary-material"/><count count-type="authors" count="10"/><fig-count count="8"/><ref-count count="68"/><page-count count="21"/><word-count count="11734"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>July 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Plant pathogenic fungi cause serious diseases, resulting in crop yield loss and reducing crop quality worldwide (<xref rid="B1" ref-type="bibr">1</xref>). To control plant disease, chemical fungicides have been widely used, but the overuse of these fungicides has led to concerns about the hazards to humans, animals, and the environment and the increase of fungicide resistance (<xref rid="B2" ref-type="bibr">2</xref>). The resistance to single&#x02010;site fungicides, including methyl benzimidazoles, demethylation inhibitors, quinone outside inhibitors (QoIs), and succinate dehydrogenase inhibitors (SDHIs), has been reported in field trials and has spread throughout fungal pathogen populations, reducing the disease control efficacy. To date, the resistance mechanisms of plant pathogenic fungi have been extensively studied in terms of the alteration and overexpression of target proteins and the efflux and degradation of fungicides (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>).</p><p>Mitochondrial respiration, or oxidative phosphorylation, is a crucial cellular process of eukaryotic cells. SDHI and QoI fungicides have been developed to inhibit mitochondrial respiration, particularly the electron transport chain (ETC). These fungicides are the dominant chemicals for crop protection against fungal pathogens because of their broad antifungal spectrum against ascomycete, basidiomycete, and oomycete pathogens (<xref rid="B5" ref-type="bibr">5</xref>). However, as a consequence of extensive and frequent use, it has been reported that the efficacy of these fungicides is gradually declining for crop protection because of increased resistance (<xref rid="B4" ref-type="bibr">4</xref>). Nevertheless, because mitochondrial respiration is indispensable for various cellular functions, including energy metabolism, and respiration inhibitors exhibit a broad antifungal spectrum, mitochondrial respiration is still an attractive target for developing fungicides (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). For the determination of respiration inhibition activity, many researchers have used a simple assay that compares yeast growth in two different liquid media containing a fermentable and non-fermentable carbon source as the sole carbon source (<xref rid="B8" ref-type="bibr">8</xref>). QoI fungicides strongly affect the growth inhibition of yeast grown in a medium containing a non-fermentable carbon source compared to growth in a fermentable carbon source (<xref rid="B8" ref-type="bibr">8</xref>). Therefore, this assay can discover useful natural resources, such as microbes and plant extracts, showing respiratory inhibition activity (<xref rid="B9" ref-type="bibr">9</xref>).</p><p>To counteract the escalating risks (e.g., toxicity and resistance issues) of chemical fungicides, interest in biological control agents (BCAs) for plant disease control has significantly increased. To find valuable BCAs, most research has focused on the antibiosis of beneficial microbes during initial screening procedures (<xref rid="B10" ref-type="bibr">10</xref>). The microbial strains from the genera <italic toggle="yes">Bacillus</italic>, <italic toggle="yes">Pseudomonas</italic>, and <italic toggle="yes">Agrobacterium</italic> have the most crucial role in biological control and have been commercialized as a biopesticides (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). It has also been reported that several <italic toggle="yes">Brevibacillus</italic> spp. exhibit a strong antimicrobial activity against plant pathogens, indicating an excellent potential for biocontrol (<xref rid="B13" ref-type="bibr">13</xref>). The genus <italic toggle="yes">Brevibacillus</italic>, one of the most common genera of Gram-positive bacteria, is distributed widely in environmental habitats and includes 20 species that produce various antimicrobial peptides (AMPs), such as tostadin, gramicidins, edeines, and tyrocidines (<xref rid="B14" ref-type="bibr">14</xref>). AMPs made by <italic toggle="yes">Brevibacillus</italic> spp. are structurally diverse and can be classified based on their biosynthesis pathway and structural traits (<xref rid="B14" ref-type="bibr">14</xref>). Moreover, these AMPs can be recognized into two groups based on the mechanism of antimicrobial action: (i) AMPs targeting cell-surface components such as cell wall and membrane-bound protein and (ii) AMPs targeting intracellular components such as ribosomes and the nucleic acid synthesis machinery (<xref rid="B14" ref-type="bibr">14</xref>). Although the antimicrobial mechanisms of AMPs have been studied extensively, more information is still needed about the detailed mode of action in fungal organisms, particularly in plant pathogenic fungi.</p><p>As a necrotrophic fungus, <italic toggle="yes">Fusarium graminearum</italic> is a highly destructive pathogen causing severe diseases in cereal crops, such as maize, wheat, barley, and rice (<xref rid="B15" ref-type="bibr">15</xref>). The infection of this pathogen causes yield loss of crops but also contaminates grains with mycotoxins that are harmful to humans and animals (<xref rid="B15" ref-type="bibr">15</xref>). Control of Fusarium head blight (FHB) caused by <italic toggle="yes">F. graminearum</italic> is highly dependent upon the application of synthetic fungicides; however, many researchers are greatly concerned about these chemical fungicides, such as carbendazim, tebuconazole, and azoxystrobin that trigger mycotoxin deoxynivalenol (DON) biosynthesis (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>). Biocontrol with BCAs can be an alternative approach to chemical control and could be used as part of the integrated management of FHB and mycotoxin production (<xref rid="B18" ref-type="bibr">18</xref>). This study aimed to find a useful microbe exhibiting respiratory inhibitory activity, considering that SDHI and QoI fungicides targeting mitochondrial respiration are biologically active against all the stages of fungal growth (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B19" ref-type="bibr">19</xref>). Furthermore, an initial discovery that the culture filtrate (CF) of the <italic toggle="yes">Brevibacillus brevis</italic> HK544 strain inhibited mitochondrial respiration led to the discovery of an active compound edeine B<sub>1</sub> (EB<sub>1</sub>) responsible for the respiration inhibition activity. The biological function of EB<sub>1</sub> through transcriptome analysis, drug-induced haploinsufficiency (DIH) analysis, and targeted mutagenesis revealed that EB<sub>1</sub> has effects on multiple aspects of respiration and that most of the mitochondrial-related genes in <italic toggle="yes">F. graminearum</italic> are downregulated by EB<sub>1</sub>. With an emphasis on understanding the molecular basis of EB<sub>1</sub> in antifungal activity, our findings show that the <italic toggle="yes">B. brevis</italic> HK544 strain could be a useful resource for developing new natural agents to control FHB.</p></sec><sec sec-type="results" id="s2"><title>RESULTS</title><sec id="s2-1"><title><italic toggle="yes">B. brevis</italic> HK544 exhibited a respiration inhibitory activity with a robust antifungal activity</title><p>In the search for new natural resources exhibiting respiratory inhibition activity, we found that the HK544 CF (20%, vol/vol) inhibited the growth of <italic toggle="yes">Saccharomyces cerevisiae</italic> in the NFYG medium but not in the YG medium, which was similar to the strobilurin fungicide kresoxim-methyl that has a role as a mitochondrial cytochrome bc1 complex inhibitor (see Fig. S1). At various concentrations, HK544 CF inhibited the growth of <italic toggle="yes">S. cerevisiae</italic> in the range of 55%&#x02013;99% when they were grown in NFYG medium, whereas the growth inhibition of <italic toggle="yes">S. cerevisiae</italic> grown in YG medium ranged from 3% to 11% (<xref rid="F1" ref-type="fig">Fig. 1A</xref>). These results suggest that the HK544 strain might produce active compounds exhibiting a respiratory inhibition activity against <italic toggle="yes">S. cerevisiae</italic>.</p><fig position="float" fig-type="figure" id="F1"><label>Fig 1</label><caption><p>Discovery of <italic toggle="yes">B. brevis</italic> HK544 exhibiting a respiratory inhibitory activity. (<bold>A</bold>) Growth comparison of <italic toggle="yes">S. cerevisiae</italic> in NFYG and YG media containing HK544 CF. PC, treatment of kresoxim-methyl (10 &#x003bc;g/mL). (<bold>B</bold>) Antifungal activity of <italic toggle="yes">B. brevis</italic> HK544. The upper layer shows a dual culture assay of HK544 strain against <italic toggle="yes">F. graminearum</italic> grown on PDA+TSA (1:1, vol/vol) medium, and the photos were taken 4 days post-inoculation (dpi) at 25&#x000b0;C. The bottom layer shows the antifungal activity of the HK544 CF against an <italic toggle="yes">F. graminearum</italic> conidial suspension. After a 24-h incubation, each well was stained with PrestoBlue reagent. (<bold>C</bold>) ATP production of <italic toggle="yes">F. graminearum</italic> mycelia treated with HK544 CF. (<bold>D</bold>) Genome-wide comparative analysis. Heatmap and dendrogram of average nucleotide identity based on the whole genome illustrating the phylogenetic relationships between the HK544 strain and nine other bacterial strains. Bars depict the number of biosynthetic gene clusters (BGCs) belonging to each genome, which were identified by antiSMASH analysis. Colored boxes represent different BGC types as provided by the legend. Asterisks indicate a statistically significant difference in mean values (<italic toggle="yes">n</italic> = 3; *<italic toggle="yes">P</italic> &#x0003c; 0.05; **<italic toggle="yes">P</italic> &#x0003c; 0.01; ***<italic toggle="yes">P</italic> &#x0003c; 0.001). NC, negative control.</p></caption><graphic xlink:href="mbio.01351-24.f001" position="float"><alt-text>Graphs plot yeast growth with and without HK544 filtrate and ATP production in fungi treated with HK544. Microgrphs feature dual culture assay and fungal spore growth with staining with genetic comparison of antifungal activity.</alt-text></graphic></fig><p>To explore the HK544 strain in the control of plant pathogenic fungi, we investigated the antifungal activity of HK544 against <italic toggle="yes">F. graminearum</italic> as a model pathogenic fungus in terms of mycelial and conidial growth. As a result, we observed that the HK544 strain inhibited the mycelial growth of <italic toggle="yes">F. graminearum</italic> based on the dual culture assay. The HK544 CF also had a minimum inhibitory concentration (MIC) of 1.25% against <italic toggle="yes">F. graminearum</italic> when a conidial suspension was used (<xref rid="F1" ref-type="fig">Fig. 1B</xref>). To investigate whether the HK544 CF has a respiratory inhibition activity against <italic toggle="yes">F. graminearum</italic>, we measured the ATP production of <italic toggle="yes">F. graminearum</italic> with and without HK544 CF treatment. When the mycelia were treated by 0.1% and 1% of the HK544 CF, the ATP production decreased by 21.9% and 64.5% compared to the non-treatment control after a 1 h treatment incubation, respectively. At 4 h after the treatment, the ATP production decreased by 83.5% and 100% compared to the non-treatment control (<xref rid="F1" ref-type="fig">Fig. 1C</xref>). These results support the possibility that the HK544 CF is involved in the respiratory inhibition of <italic toggle="yes">F. graminearum</italic>.</p><p>The HK544 strain was previously identified as a <italic toggle="yes">B. brevis</italic> at the genome level (<xref rid="B20" ref-type="bibr">20</xref>). Prior to the chemical identification of the respirator inhibitor from <italic toggle="yes">B. brevis</italic> HK544 CF, we analyzed and compared the secondary metabolites derived from the HK544 genome with several <italic toggle="yes">Brevibacillus</italic> and <italic toggle="yes">Bacillus</italic> species (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>). Based on the antiSMASH analysis, we found that <italic toggle="yes">B. brevis</italic> HK544 contains 17 biosynthesis gene clusters (BGCs), including non-ribosomal peptide, polyketide synthases, and post-translationally modified peptide clusters, suggesting that the HK544 strain can produce various bioactive compounds such as tyrocidine and zwittermicin A (<xref rid="F1" ref-type="fig">Fig. 1D</xref>). When compared with other <italic toggle="yes">Brevibacillus</italic> spp., the composition of HK544 BGCs was similar with other <italic toggle="yes">Brevibacillus</italic> spp. although the number of BGCs differed (<xref rid="F1" ref-type="fig">Fig. 1D</xref>). Based on the previously reported bioactive compounds from <italic toggle="yes">B. brevis</italic>, limited information is available regarding the respiratory inhibitory activity of the bioactive compounds by <italic toggle="yes">B. brevis</italic>.</p></sec><sec id="s2-2"><title><italic toggle="yes">B. brevis</italic> HK544 produced EB<sub>1</sub> as a major active compound for respiratory inhibition</title><p>To isolate the active compounds showing respiratory inhibition activity from the <italic toggle="yes">B. brevis</italic> HK544 CF, we performed chromatography analyses based on the growth comparison of <italic toggle="yes">S. cerevisiae</italic> in NFYG and YG media. Consequently, the active compound HKC1 (117 mg) was obtained as colorless needles from the HK544 CF. The UV/Vis spectrum of HKC1 showed an end absorbance below 210 nm. The electrospray ionization mass spectrometry (ESI-MS) spectrum of HKC1 showed molecular ions at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 797 [M+H]<sup>+</sup> and m/z 819 [M+Na]<sup>+</sup>. The nuclear magnetic resonance (NMR) data of HKC1 (see Table S1) wholly agreed with those of EB<sub>1</sub>, which is comprised of &#x003b2;-tyrosine, &#x003b2;<italic toggle="yes">-</italic>serine, &#x003b1;<italic toggle="yes">,</italic>&#x003b2;-diamino-propionic acid, &#x003b1;-2,6-diamino-7-hydroxyazelaic acid, glycine, and polyamine (<xref rid="F2" ref-type="fig">Fig. 2A</xref>) (<xref rid="B23" ref-type="bibr">23</xref>). EB<sub>1</sub> inhibited the growth of <italic toggle="yes">S. cerevisiae</italic> in the NFYG medium in a dose-dependent manner. In contrast, growth inhibition in the YG medium was less than 6% at the tested concentrations (<xref rid="F2" ref-type="fig">Fig. 2B</xref>). These results suggest that EB<sub>1</sub> has effects on the respiration of <italic toggle="yes">S. cerevisiae</italic>.</p><fig position="float" fig-type="figure" id="F2"><label>Fig 2</label><caption><p>Identification of EB<sub>1</sub> from <italic toggle="yes">B. brevis</italic> HK544 as an active compound for respiratory inhibition. (<bold>A</bold>) Chemical structure of EB<sub>1</sub>. DAPA, &#x003b1;,&#x003b2;-diamino-propionic acid; DAHAA, &#x003b1;-2,6-diamino-7-hydroxyazelaic acid. (<bold>B</bold>) Respiratory inhibition activity of EB<sub>1</sub> based on the growth comparison of <italic toggle="yes">S. cerevisiae</italic> in NFYG and YG media containing EB<sub>1</sub>. PC, treatment of kresoxim-methyl (10 &#x003bc;g/mL). (<bold>C</bold>) Inhibitory effects of EB<sub>1</sub> on the conidial germination of <italic toggle="yes">F. graminearum</italic>. (<bold>D</bold>) Inhibitory effects of EB<sub>1</sub> on the mycelial growth of <italic toggle="yes">F. graminearum</italic>. (<bold>E</bold>) Mycelial growth and morphological observation of <italic toggle="yes">F. graminearum</italic> on complete medium (CM) supplemented with EB<sub>1</sub>. Scale bar, 10 &#x003bc;m. (<bold>F</bold>) Effects of EB<sub>1</sub> on fungal membrane permeability. The conidial suspension was treated with EB<sub>1</sub> and then stained with propidium iodide. The conidia were treated with 70% aqueous ethanol as a positive control. Scale bar, 50 &#x000b5;m. (<bold>G</bold>) Inhibition of protein synthesis by EB<sub>1</sub> in germinating conidia of <italic toggle="yes">F. graminearum</italic> wild-type strain. Newly synthesized proteins were visualized using the Click-iT protein synthesis assay kit and quantified by relative fluorescence intensity. Scale bar, 50 &#x000b5;m. (<bold>H</bold>) Inhibitory effects of the combinations of EB<sub>1</sub> and cycloheximide on protein synthesis of <italic toggle="yes">F. graminearum</italic> wild-type strain. Scale bar, 50 &#x000b5;m. Asterisks indicate a statistically significant difference in mean values (<italic toggle="yes">n</italic> = 3; *<italic toggle="yes">P</italic> &#x0003c; 0.05; **<italic toggle="yes">P</italic> &#x0003c; 0.01; **<italic toggle="yes">P</italic> &#x0003c; 0.001).</p></caption><graphic xlink:href="mbio.01351-24.f002" position="float"><alt-text>Structure of edeine B1 EB1; quantification of fungus growth with and without EB1; fungi morphology after EB1 treatment, with increased stain uptake due to EB1, and reduced protein synthesis after EB1 treatment in micrographs are featured.</alt-text></graphic></fig><p>To explore how EB<sub>1</sub> inhibits the growth of <italic toggle="yes">F. graminearum</italic>, we investigated the inhibitory activity of EB<sub>1</sub> for conidial germination and mycelial growth. When <italic toggle="yes">F. graminearum</italic> conidia were treated with EB<sub>1</sub>, conidial germination was inhibited in a dose-dependent manner compared to the non-treatment control; at a concentration of 20 &#x000b5;g/mL, the conidial germination was inhibited by 75% (<xref rid="F2" ref-type="fig">Fig. 2C</xref>). Furthermore, at the same concentration, we observed that EB<sub>1</sub> has higher antifungal activity for inhibiting conidial germination compared to mycelial growth (<xref rid="F2" ref-type="fig">Fig. 2C and D</xref>). Considering that AMPs can cause morphological changes in the plasma membrane and cell wall and increase cell permeability, we observed morphological alterations on <italic toggle="yes">F. graminearum</italic> grown on potato dextrose agar (PDA) medium supplemented with EB<sub>1</sub>. The morphology of hyphae treated with EB<sub>1</sub> was similar to that of the normal control hyphae based on SEM observation (<xref rid="F2" ref-type="fig">Fig. 2E</xref>). When conidia treated with EB<sub>1</sub> (10 &#x000b5;g/mL) were stained by propidium iodide, the EB<sub>1</sub>-treated conidia exhibited no red fluorescence similar to the non-treatment control (<xref rid="F2" ref-type="fig">Fig. 2F</xref>). By contrast, ethanol-treated conidia as a positive control exhibited a much stronger red fluorescence than that of the control and EB<sub>1</sub> treatment (<xref rid="F2" ref-type="fig">Fig. 2F</xref>), suggesting that EB<sub>1</sub> did not trigger fungal cell membrane defects. Given that EB<sub>1</sub> exhibits respiratory inhibition activity, we observed the mitochondria of <italic toggle="yes">F. graminearum</italic> treated with EB<sub>1</sub> using transmission electron microscopy. Our results showed that there were no observable morphological changes in mitochondrial structure by EB<sub>1</sub> treatment (see Fig. S2). Furthermore, along with no morphological changes of mitochondria, we observed there was no change in mitochondrial superoxide generation in <italic toggle="yes">F. graminearum</italic> treated with EB<sub>1</sub> (see Fig. S3). Taken together, our results suggest that EB<sub>1</sub> seems to indirectly regulate mitochondrial respiration in <italic toggle="yes">F. graminearum</italic>.</p><p>Considering that the peptide antibiotic edeine binds between the P-site and the E-site of the small subunit of the ribosome and consequently impairs protein synthesis (<xref rid="B24" ref-type="bibr">24</xref>), we investigated the effects of EB<sub>1</sub> on protein synthesis based on fluorescence in fungal cells. As a result, we observed strong green fluorescence signals from the germinated conidia of <italic toggle="yes">F. graminearum</italic> (<xref rid="F2" ref-type="fig">Fig. 2G</xref>). However, when <italic toggle="yes">F. graminearum</italic> was treated with 5 and 10 &#x000b5;g/mL of EB<sub>1</sub>, the fluorescence intensity was reduced by 72% and 91%, respectively (<xref rid="F2" ref-type="fig">Fig. 2G</xref>); as a positive control, we observed that a translation inhibitor cycloheximide treatment also exhibited a reduced fluorescence intensity (<xref rid="F2" ref-type="fig">Fig. 2H</xref>). Furthermore, when <italic toggle="yes">F. graminearum</italic> was co-treated with EB<sub>1</sub> and cycloheximide, the fluorescence intensity decreased more than that of the single treatment, supporting that EB<sub>1</sub> and cycloheximide target different sites on the eukaryotic ribosome (<xref rid="B24" ref-type="bibr">24</xref>).</p></sec><sec id="s2-3"><title>EB<sub>1</sub> downregulated genes involved in oxidative phosphorylation</title><p>Considering that edeines have been widely used as transcriptional inhibitors to study ribosomal function and protein synthesis (<xref rid="B25" ref-type="bibr">25</xref>), we performed transcriptomic analysis of the <italic toggle="yes">F. graminearum</italic> wild-type strain from which the fungal mycelia were treated with EB<sub>1</sub> and incubated for 1, 2, and 4 h (<xref rid="F3" ref-type="fig">Fig. 3A</xref>). We considered differentially expressed genes (DEGs) showing differences in transcript accumulation with a log<sub>2</sub> fold change of greater than 1 or less than &#x02212;1 (<italic toggle="yes">P</italic> &#x0003c; 0.05). Compared to the non-treatment control, a total of 7,876 DEGs were identified from <italic toggle="yes">F. graminearum</italic> mycelia, with 982 and 635 genes exhibiting a significant increase and decrease in all time points, respectively (<xref rid="F3" ref-type="fig">Fig. 3B</xref>). Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis on the 1,617 DEGs revealed that the up- and downregulated genes were mainly enriched in &#x0201c;ubiquinone and other terpenoid-quinone biosynthesis (fgr00130),&#x0201d; &#x0201c;pentose phosphate pathway (fgr00030),&#x0201d; &#x0201c;glycolysis/gluconeogenesis (fgr00010),&#x0201d; &#x0201c;ABC transporters (fgr02010),&#x0201d; and &#x0201c;nucleotide metabolism (fgr01232)&#x0201d; (<xref rid="F3" ref-type="fig">Fig. 3C</xref>). In particular, all analyzed genes within the &#x0201c;ubiquinone and other terpenoid-quinone biosynthesis&#x0201d; pathway exhibited changes in expression levels in the samples treated with EB<sub>1</sub> for 4 h (<xref rid="F3" ref-type="fig">Fig. 3D</xref>). Given the crucial role of ubiquinone as a key component of the electron transport chain in the oxidative phosphorylation process (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>), these results imply that EB<sub>1</sub> has effects on oxidative phosphorylation. Furthermore, when Gene Ontology (GO) enrichment analysis was performed, the DEGs were highly enriched in GO terms related to ribosomal function such as rRNA processing (GO:0006364), ribosome biogenesis (GO:0042254), and ribosomal large subunit assembly (GO:0000027) in the biological process category (see Fig. S4). In the category of molecular function, ATP binding (GO:0005524) was a dominant term, and translation initiation-related GO terms were identified, including translation initiation factor activity (GO:0003743), RNA helicase activity (GO:0003724), and translation initiation factor binding (GO:0031369). For the cellular component, the DEGs were enriched in nucleolus (GO:0005730), mitochondrion (GO:0005739), and mitochondrial inner membrane (GO:0005743). These results suggest that EB<sub>1</sub> may play an important role in the ribosome biogenesis, translation, and mitochondrial function of <italic toggle="yes">F. graminearum</italic>.</p><fig position="float" fig-type="figure" id="F3"><label>Fig 3</label><caption><p>Transcriptome analysis of <italic toggle="yes">F. graminearum</italic> treated with EB<sub>1</sub>. (<bold>A</bold>) Hierarchical clustering heat map of DEGs in three biological replications of different time points after the EB<sub>1</sub> treatment. The red and blue colors denote highly and weakly expressed genes, respectively. The color gradient represents the Z-score for the log<sub>2</sub> FC-based normalized values. (<bold>B</bold>) Venn diagrams representing the number of differentially up- and downregulated genes. The number of overlapping genes is found in both conditions. (<bold>C</bold>) Top 10 enriched KEGG pathways of the DEGs. (<bold>D</bold>) Visualization of the expression of genes enriched in the KEGG pathway &#x0201c;ubiquinone and other terpenoid-quinone biosynthesis.&#x0201d; The color gradient represents the fold change value of genes from the EB<sub>1</sub> 4-h treatment compared to the non-treatment control.</p></caption><graphic xlink:href="mbio.01351-24.f003" position="float"><alt-text>Heatmap with DEGs across time points; Venn diagrams with numbers showing overlap between up- and downregulated genes; graph with enriched KEGG pathways in DEGs; and expression changes in genes of a specific KEGG pathway are featured.</alt-text></graphic></fig><p>Considering that EB<sub>1</sub> exhibited a respiratory inhibition activity against <italic toggle="yes">S. cerevisiae</italic>, we further explored genes involved in oxidative phosphorylation of <italic toggle="yes">F. graminearum</italic> based on the KEGG database. From the RNA-Seq results, we selected 47 genes for the ETC of mitochondria. These genes were mostly downregulated 2 and 4 h after EB<sub>1</sub> treatment, except for FGSG_01981 and FGSG_04854, which encode succinate dehydrogenase and ATP synthase, respectively (<xref rid="F4" ref-type="fig">Fig. 4A</xref>). To validate the RNA-Seq results, we arbitrarily selected eight genes, seven downregulated genes, and one upregulated gene, for quantitative real-time PCR (qRT-PCR) analysis. Although the fold changes were different, the expression trends of these eight genes were consistent in both the RNA-Seq and qRT-PCR results (<xref rid="F4" ref-type="fig">Fig. 4B</xref>).</p><fig position="float" fig-type="figure" id="F4"><label>Fig 4</label><caption><p>Differential expression of genes involved in oxidative phosphorylation of <italic toggle="yes">F. graminearum</italic>. (<bold>A</bold>) Heatmap visualization of transcriptional profiles of oxidative phosphorylation genes. The red and blue colors denote highly and weakly expressed genes, respectively. The color gradient represents the Z-score for the log<sub>2</sub> FC-based normalized values. C I&#x02013;IV, respiratory chain complex I&#x02013;IV; AS, ATP synthase. (<bold>B</bold>) Validation of the representative DEGs using qRT-PCR. Asterisks indicate a statistically significant difference in mean values (<italic toggle="yes">n</italic> = 3; *<italic toggle="yes">P</italic> &#x0003c; 0.05; **<italic toggle="yes">P</italic> &#x0003c; 0.01).</p></caption><graphic xlink:href="mbio.01351-24.f004" position="float"><alt-text>Heatmap features expression of oxidative phosphorylation genes, CI-CIV, AS, after treatment. Graphs validate relative expression of selected genes with control versus treatment.</alt-text></graphic></fig></sec><sec id="s2-4"><title>Haploinsufficiency profiling of <italic toggle="yes">Schizosaccharomyces pombe</italic> strains treated with EB<sub>1</sub></title><p>To further investigate mitochondrial-related genes affected by EB<sub>1</sub>, we exploited a DIH assay with heterozygous deletion mutants of 342 genes related to mitochondria among a <italic toggle="yes">Schizosaccharomyces pombe</italic> genome-wide deletion mutant library (4,845 genes). EB<sub>1</sub> showed potent antifungal activity against wild-type <italic toggle="yes">S. pombe</italic> cells for 21 h (GI<sub>50</sub> = 80 &#x000b5;M; see Fig. S5). DIH by EB<sub>1</sub> in various <italic toggle="yes">S. pombe</italic> heterozygous deletion mutants revealed that the fitness scores of 10 gene deletion mutants were over 2.5 among the mutants, and a <italic toggle="yes">mpc1</italic>-deleted strain had the highest fitness value of 3.99 (<xref rid="F5" ref-type="fig">Fig. 5A and B</xref>). Among the <italic toggle="yes">F. graminearum</italic> homologs to the 10 <italic toggle="yes">S. pombe</italic> genes, we found that six homologs were differentially expressed in response to EB<sub>1</sub> (<xref rid="F5" ref-type="fig">Fig. 5C</xref>). In particular, two genes FGSG_09250 encoding NADH dehydrogenase flavoprotein 1 in mitochondrial respiratory chain complex I and FGSG_07074 encoding mitochondrial pyruvate carrier 1 were assigned to the oxidative phosphorylation pathway (fgr00190) and mitochondrial biogenesis (fgr03029) of <italic toggle="yes">F. graminearum</italic> KEGG database, respectively. To further determine whether the target deletion of six homologs (FGSG_07074, 08530, 09250, 09683, 13011, and 13152) leads to chemical sensitivity to EB<sub>1</sub>, we generated gene deletion strains (see Fig. S6) and compared the growth of the wild-type and the deletion strains according to the treatment of EB<sub>1</sub>. As a result, we found that there was no significant difference in EB<sub>1</sub> sensitivity between the wild-type and deletion strains (see Fig. S7).</p><fig position="float" fig-type="figure" id="F5"><label>Fig 5</label><caption><p>Identification of potential targets of EB<sub>1</sub> using the <italic toggle="yes">S. pombe</italic> mutants. (<bold>A</bold>) <italic toggle="yes">S. pombe</italic> deletion mutants of the mitochondrial-related functional group subset were treated with the GI<sub>50</sub> value (80 &#x003bc;M) of EB<sub>1</sub>. The fitness values of each mutant based on the cell growth inhibition were plotted as the mean of three biological replicates. Red dots indicate the top 10 target candidates of EB<sub>1</sub>. (<bold>B</bold>) Description of the top 10 target candidates of EB<sub>1</sub>. (<bold>C</bold>) Transcript levels of <italic toggle="yes">F. graminearum</italic> homologs to the target candidates derived from the RNA-Seq results. The red and blue colors denote highly and weakly expressed genes, respectively. The color gradient represents the Z-score for the log<sub>2</sub> FC-based normalized values.</p></caption><graphic xlink:href="mbio.01351-24.f005" position="float"><alt-text>Graph plots fitness values across S. pombe deletion mutants along with a list of top target candidates and a heatmap of transcript levels of Fusarium graminearum genes similar to the target candidates identified in S. pombe.</alt-text></graphic></fig></sec><sec id="s2-5"><title>Deletion of <italic toggle="yes">FgSdhC1</italic> increased the sensitivity to EB<sub>1</sub></title><p>Considering that EB<sub>1</sub> changed the expression of genes involved in oxidative phosphorylation, we explored whether SDHI and QoI fungicides have effects on the transcript level of succinate dehydrogenase (<italic toggle="yes">FgSdhC1</italic>; FGSG_01981) and cytochrome c oxidase (<italic toggle="yes">FgCox7A</italic>; FGSG_09879) subunits. They were selected because their expressions were significantly increased and decreased by EB<sub>1</sub>, respectively (<xref rid="F6" ref-type="fig">Fig. 6A</xref>). <italic toggle="yes">FgSdhC1</italic> was highly induced and suppressed by the SDHI fungicide fluopyram and QoI fungicide kresoxim-methyl, respectively, and both chemicals suppressed <italic toggle="yes">FgCox7A</italic>. These results were sillier than the RNA-Seq and qRT-PCR results derived from the EB<sub>1</sub> treatment. However, in contrast to the EB<sub>1</sub> treatment results, we observed that <italic toggle="yes">FgCox7A</italic> was induced by both chemicals 1 h after the treatment (<xref rid="F6" ref-type="fig">Fig. 6A</xref>).</p><fig position="float" fig-type="figure" id="F6"><label>Fig 6</label><caption><p>Effects of chemical fungicides and EB<sub>1</sub> on <italic toggle="yes">F. graminearum</italic> strains. (<bold>A</bold>) Transcript levels of the genes encoding the putative succinate dehydrogenase (FGSG_01981) and cytochrome c oxidase (FGSG_09879) subunit by treatment of chemical fungicides. (<bold>B</bold>) Growth inhibition effects of EB<sub>1</sub> and fluopyram on the &#x00394;01981 strain. FgWT, <italic toggle="yes">F. graminearum</italic> wild-type strain; &#x00394;01981, an FGSG_01981 gene deletion strain. Asterisks indicate a statistically significant difference in mean values (<italic toggle="yes">n</italic> = 3; *<italic toggle="yes">P</italic> &#x0003c; 0.05; **<italic toggle="yes">P</italic> &#x0003c; 0.01).</p></caption><graphic xlink:href="mbio.01351-24.f006" position="float"><alt-text>Graphs plot relative expression of FCSG01981 and 09879 across incubation time under 1 percent DMSO, Fluopyram, and Kresoxim methyl and growth inhibition percent across EB 1 and Fluopyram for FgWT and variant lacking 01981.</alt-text></graphic></fig><p>To further determine whether the deletion of succinate dehydrogenase genes leads to chemical sensitivity to EB<sub>1</sub>, we generated an <italic toggle="yes">FgSdhC1</italic> deletion strain that was named &#x00394;01981 (see Fig. S8) and compared the growth of the wild-type and &#x00394;01981 strains according to the treatment of EB<sub>1</sub>. As a result, the &#x00394;01981 strain was more sensitive to EB<sub>1</sub> compared to the wild-type strain below a concentration of 12.5 &#x000b5;g/mL; in particular, the greatest difference (2.7-fold) was shown at a concentration of 3.1 &#x000b5;g/mL (<xref rid="F6" ref-type="fig">Fig. 6B</xref>). In addition, when we investigated the growth difference to fluopyram which binds to the ubiquinone-binding sites in the succinate dehydrogenase complex composed of four subunits (SdhA, SdhB, SdhC, and SdhD), the deletion of <italic toggle="yes">FgSdhC1</italic> also led to a change in fluopyram sensitivity (<xref rid="F6" ref-type="fig">Fig. 6B</xref>). Therefore, our observations that the deletion of <italic toggle="yes">FgSdhC1</italic> increased the sensitivity to EB<sub>1</sub> support that EB<sub>1</sub> has effects on the mitochondrial respiration of <italic toggle="yes">F. graminearum</italic>.</p></sec><sec id="s2-6"><title>HK544 CF and EB<sub>1</sub> reduced the development of FHB</title><p>As proof of concept that the <italic toggle="yes">in vivo</italic> antifungal activity of HK544 CF and EB<sub>1</sub> can be used as a BCA, we investigated their ability to control or reduce the FHB by treating flowering wheat heads with HK544 CF and EB<sub>1</sub> before inoculation with <italic toggle="yes">F. graminearum</italic> conidial suspension. The non-treatment control exhibited typical head blight symptoms, which manifested as discoloration, at 5 days post-inoculation (dpi), whereas the treatments with HK544 CF and EB<sub>1</sub> led to suppressed FHB development in a dose-dependent manner (<xref rid="F7" ref-type="fig">Fig. 7A and B</xref>). In addition, given that chemical fungicides inhibiting mitochondrial respiration induce trichothecene production of <italic toggle="yes">F. graminearum</italic> (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>), we investigated whether HK544 CF containing EB<sub>1</sub> induces trichothecene production. The results showed that the cultures treated with HK544 CF produced reduced trichothecenes in a dose-dependent manner without the differential expression of the trichothecene biosynthetic genes <italic toggle="yes">TRI5</italic> (FGSG_03537; trichodiene synthase) and <italic toggle="yes">TRI6</italic> (FGSG_03536; transcription factor) between the treated and untreated cultures (<xref rid="F7" ref-type="fig">Fig. 7C and D</xref>). This result suggests that the reduced trichothecene production is from the inhibition of fungal growth by HK544 CF. Taken together, our results indicate that <italic toggle="yes">B. bacillus</italic> HK544 CF can control FHB with a reduction of trichothecene production.</p><fig position="float" fig-type="figure" id="F7"><label>Fig 7</label><caption><p>FHB control efficacy and trichothecene analysis. (<bold>A</bold>) Each wheat head was inoculated with an <italic toggle="yes">F. graminearum</italic> conidial suspension (1 &#x000d7; 10<sup>6</sup> conidia/mL) 24 h after treatment with HK544 CF and EB<sub>1</sub>. NC, non-treatment control; Mock, mock inoculation was performed with the 0.025% Tween 20 solution. The photos were taken at 5 dpi. (<bold>B</bold>) The disease control efficacy (%) was calculated by the lesion area (%) of wheat heads compared to the non-treatment control. (<bold>C</bold>) Trichothecenes were extracted from 7-day-old cultures in liquid minimal medium including agmatine (MMA) supplemented with or without HK544 CF and quantified by gas chromatograph-mass spectrometer (GC-MS). (<bold>D</bold>) Transcript levels of the trichothecene biosynthetic genes <italic toggle="yes">Tri5</italic> and <italic toggle="yes">Tri6</italic> were measured by qRT-PCR from 4-day-old cultures in liquid MMA medium supplemented with or without HK544 CF. Different letters indicate a statistically significant difference at <italic toggle="yes">P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="mbio.01351-24.f007" position="float"><alt-text>Wheat heads with treatments, control, mock, HK544, EB1, and fungal inoculation; graphs plotting disease control efficacy based on lesion area,amount of trichothecene toxins, and gene expression levels of Tri5 and Tri6 are featured.</alt-text></graphic></fig></sec><sec id="s2-7"><title>Synergistic effects of the combinations of EB<sub>1</sub> and respiratory inhibitors</title><p>Considering that the combination assay can provide information on improved antifungal potency for the application and also help unravel the mechanism of action of the drugs, we investigated the synergistic effects between EB<sub>1</sub> and ETC inhibitors (rotenone for complex I, thenoyltrifluoroacetone (TTFA) for complex II, antimycin A for complex III, and potassium cyanide (KCN) for complex IV) against <italic toggle="yes">F. graminearum</italic>. First, we determined the MIC values of each ETC inhibitor against <italic toggle="yes">F. graminearum</italic>. The results showed that the MICs of rotenone and antimycin A were above the highest concentration tested (&#x0003e;200 &#x000b5;g/mL), and TTFA and KCN had MIC values of 25 and 12.5 &#x000b5;g/mL, respectively (<xref rid="F8" ref-type="fig">Fig. 8</xref>). Because the fractional inhibitory concentration index estimates the drug interactions at the MIC levels, we used a zero interaction potency (ZIP) model to understand the interactions over the entire range of concentrations (<xref rid="B28" ref-type="bibr">28</xref>). When EB<sub>1</sub> (ranging from 1.6 to 25 &#x02009;&#x000b5;g/mL; MIC value of 12.5 &#x02009;&#x000b5;g/mL; see Fig. S9) was combined with ETC inhibitors, the highest average synergy score (18.337) was observed in the combination of EB<sub>1</sub> + rotenone among the tested combinations although the 2D and 3D plots of the model-specific statistic showed regions of synergy in all the tested combinations (<xref rid="F8" ref-type="fig">Fig. 8</xref>). An EB<sub>1</sub> + TTFA combination exhibited the lowest average synergy score (0.796) and also showed regions of antagonism in the matrix (<xref rid="F8" ref-type="fig">Fig. 8</xref>).</p><fig position="float" fig-type="figure" id="F8"><label>Fig 8</label><caption><p>Synergistic effects of the combinations of EB<sub>1</sub> and respiratory inhibitors on <italic toggle="yes">F. graminearum</italic>. In each drug combination (A&#x02013;F), ZIP synergy scores based on the <italic toggle="yes">F. graminearum</italic> growth were calculated by the SynergyFinder software, and the interaction landscapes are shown in both 2D (left) and 3D (right) with red color (synergism) and green color (antagonism). The summary ZIP score calculated over the full dose-response matrix and landscape is marked on top of the panels. The gray-shaded area with a white line indicates the most synergistic area in that particular dose-response matrix.</p></caption><graphic xlink:href="mbio.01351-24.f008" position="float"><alt-text>2D and 3D plots with color gradients representing synergy and antagonism for EB1 combined with TTFA, KCN, rotenone, antimycin, fluopyram, and fenazaquin on fungal growth with score and shaded area indicating most synergistic drug concentrations.</alt-text></graphic></fig><p>Based on our observation that the combinations EB<sub>1</sub> + rotenone and EB<sub>1</sub> + TTFA exhibit the highest and lowest average synergy scores, respectively, we further investigated the synergistic interactions between EB<sub>1</sub> and commercial fungicides targeting complexes I and II. When EB<sub>1</sub> was combined with the complex I inhibitor fenazaquin (MIC, &#x0003e;200 &#x000b5;g/mL) and complex II inhibitor fluopyram (MIC, 100 &#x000b5;g/mL), the average ZIP score was 14.107 and 5.864 (<xref rid="F8" ref-type="fig">Fig. 8</xref>), respectively, suggesting that there was a synergistic effect between EB<sub>1</sub> and the complex I inhibitor fenazaquin. These results show that EB<sub>1</sub> synergistically interacts with complex I inhibitors rotenone and fenazaquin for the respiratory inhibition of <italic toggle="yes">F. graminearum</italic>.</p></sec></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p>The mitochondrial machinery facilitating ATP synthesis by oxidative phosphorylation is a promising target for active compounds derived from microbial metabolites (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B29" ref-type="bibr">29</xref>). The natural compound strobilurin A was discovered in the wood-rotting basidiomycete fungus <italic toggle="yes">Strobilurus tenacellus</italic>, and synthetic strobilurin fungicides (e.g., azoxystrobin and kresoxim-methyl) were developed from &#x003b2;-methoxyacrylate through optimization of their photostability and activity (<xref rid="B5" ref-type="bibr">5</xref>). Although fungicides targeting mitochondrial respiration are the dominant chemical groups used in the market (<xref rid="B30" ref-type="bibr">30</xref>), it has been reported that strobilurin fungicides do not inhibit the respiration of several fungal pathogens, such as <italic toggle="yes">Magnaporthe oryzae</italic> and <italic toggle="yes">Botrytis cinerea</italic>, in which an alternative oxidase is activated (<xref rid="B31" ref-type="bibr">31</xref><xref rid="B32" ref-type="bibr">&#x02013;</xref><xref rid="B33" ref-type="bibr">33</xref>). Respiration is maintained through an alternative pathway when strobilurin binds to cytochrome bc<sub>1</sub> complex in the ETC (<xref rid="B31" ref-type="bibr">31</xref><xref rid="B32" ref-type="bibr">&#x02013;</xref><xref rid="B33" ref-type="bibr">33</xref>). Due to issues of resistance and reduced effectiveness for these chemicals in several fungal pathogens, this study aimed to find natural resources exhibiting respiratory inhibitory activity. To this end, numerous microbial CFs were explored using a yeast screening system for their respiratory inhibitory activity. As a result, we found a soil-borne microbe <italic toggle="yes">B. brevis</italic> HK544 strain, and identified EB<sub>1</sub> as an active compound for the respiration inhibition activity.</p><p><italic toggle="yes">Brevibacillus</italic> is a genus of bacteria reclassified from <italic toggle="yes">Bacillus</italic> based on the 16S rRNA sequence analysis (<xref rid="B14" ref-type="bibr">14</xref>). This genus has been considered a rich resource for antibacterial and antifungal activity with the isolation and characterization of many active compounds such as gramicidin S, tyrocidines, tauramamide, bogorols, and laterosporulin (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B34" ref-type="bibr">34</xref><xref rid="B35" ref-type="bibr">&#x02013;</xref><xref rid="B36" ref-type="bibr">36</xref>). Most of the peptides produced by <italic toggle="yes">Brevibacillus</italic> have been known to damage the cytoplasmic membrane, but edeines exhibit a different mode of action from most <italic toggle="yes">Brevibacillus</italic> peptides (<xref rid="B14" ref-type="bibr">14</xref>). Edeines initially identified in <italic toggle="yes">B. brevis</italic> Vm4 are linear non-ribosomal peptides with a structurally unusual backbone that includes four non-proteinogenic amino acids and an N-terminal polyamine cap (<xref rid="B37" ref-type="bibr">37</xref>). This unique structure of edeines contributes to various biological functions, inhibiting the growth of numerous bacteria, fungi, mycoplasma, and tumor cells (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>). Furthermore, it has been reported that low concentrations of edeines inhibit DNA synthesis (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B40" ref-type="bibr">40</xref>). In contrast, high concentrations of edeine prevent translation initiation by inhibiting the binding of fMet-tRNA to the P site of the 30S ribosomes in prokaryotes (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B41" ref-type="bibr">41</xref>). Although significant progress has been made by the docking model between edeine and prokaryotic/eukaryotic ribosomes, relatively little is known mechanistically about the biological function of edeines, particularly against plant pathogenic fungi. In this study, EB<sub>1</sub> exhibited a respiratory inhibition activity against the necrotrophic fungus <italic toggle="yes">F. graminearum</italic> with low ATP production and downregulation of ETC genes. Additionally, the deletion of <italic toggle="yes">FgSdhC1</italic>, one of the succinate dehydrogenase complex components in ETC, increased the sensitivity of <italic toggle="yes">F. graminearum</italic> to EB<sub>1</sub>. With previous reports that edeines inhibit protein synthesis by binding to ribosomes, our results postulated that EB<sub>1</sub> inhibits the growth of <italic toggle="yes">F. graminearum</italic> by inhibiting mitochondrial translation. This hypothesis can be explained by the fact that some ribosome-targeting antibiotics can inhibit mitoribosomes, considering that mitochondria are of prokaryotic origin, and the bacterial and mitochondrial protein translation machinery share similarities (<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>). Indeed, tetracycline binding to ribosome subunits has been reported to interfere with mitochondrial proteostasis, leading to changes in nuclear gene expression and altered mitochondrial dynamics and function in eukaryotes (<xref rid="B44" ref-type="bibr">44</xref>). When we calculated the predicted binding free energies with molecular dynamics simulations to compare the binding affinity of EB<sub>1</sub> to mitochondrial ribosome and cytosolic ribosome, our results showed that the EB<sub>1</sub> in the mitochondria ribosome exhibited higher binding affinity than cytosolic ribosome although the EB<sub>1</sub> can bind to both ribosomes which were located in cytosolic and mitochondria (see Table S2). Therefore, our results cannot exclude the possibility that inhibition of mitochondrial respiration by EB<sub>1</sub> is a major byproduct of an antibiotic-target interaction.</p><p>Biological control by antagonistic microbes, including yeasts, fungi, and bacteria, can be used to manage fungal diseases, and the BCAs can also solve the resistance and toxicity issues derived from chemical pesticides (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>). Although numerous antagonistic strains of <italic toggle="yes">Brevibacillus</italic> spp. have been identified, most research has focused on <italic toggle="yes">in vitro</italic> antifungal activity with identifying active compounds, not disease control efficacy. In this study, we showed that the reduction of FHB by HK544 CF and EB<sub>1</sub> ranged from 54% to 96% at the tested concentrations. Unlike the chemical fungicides triggering mycotoxins (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>), the HK544 CF reduced trichothecene production in the cultures, suggesting that <italic toggle="yes">B. brevis</italic> HK544 can decrease both fungal growth and trichothecene production. Furthermore, our observation that EB<sub>1</sub> inhibited the fungal growth more effectively with the complex I inhibitor fenazaquin suggests that EB<sub>1</sub> is a potent chemosensitizer. These findings provide further information for the effectiveness of its <italic toggle="yes">in vivo</italic> antifungal activity, given that the disease control efficacy of <italic toggle="yes">B. brevis</italic> HK544 seems to be insufficient when used alone. Considering that antifungal chemosensitization is a novel antifungal intervention strategy in which one drug is used to enhance the efficacy of conventional agents against fungal pathogens (<xref rid="B46" ref-type="bibr">46</xref>), our results suggest that <italic toggle="yes">B. brevis</italic> HK544 could be used in combination with chemical fungicides to enhance the efficacy of antifungal agents. Further research, such as the formulation of HK544, field trials with a mixture of HK544 and chemicals, and HK544 sensitivity analyses against chemical fungicides, will be necessary to prove the feasibility of the <italic toggle="yes">B. brevis</italic> HK544 as a chemosensitizer for FHB control.</p><p>Regarding <italic toggle="yes">in vitro</italic> antifungal activity, we observed that EB<sub>1</sub> is more effective against conidial germination than mycelial growth. Similarly, it has been reported that chemical fungicides targeting mitochondrial respiration exhibit better fungicidal activity against spore germination than mycelial growth in many filamentous fungi (<xref rid="B16" ref-type="bibr">16</xref>). For example, the mycelial growth of <italic toggle="yes">B. cinerea</italic> was less sensitive to the SDHI fungicides fluopyram and boscalid compared to conidial germination (<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>). A similar dominant effect on the inhibition of spore germination has also been described from the QoI fungicides (<xref rid="B16" ref-type="bibr">16</xref>). This phenomenon can be explained by the differences in the target site sensitivity and physiological processes between spores and mycelia (<xref rid="B49" ref-type="bibr">49</xref>). Considering that SDHI and QoI fungicides target energy production in the mitochondria, and fungal spores have a lower metabolic activity with the transient softer cell walls compared to the growing mycelia, mitochondrial respiration inhibitors can lead to the different susceptibility between spores and mycelia (<xref rid="B5" ref-type="bibr">5</xref>). Therefore, we speculate that EB<sub>1</sub> has a similar action with SDHI and QoI fungicides in inhibiting fungal development.</p><p>In summary, our findings shed light on the <italic toggle="yes">in vitro</italic> antifungal activity of <italic toggle="yes">B. brevis</italic> HK544 and its major active compound EB<sub>1</sub>, with multifaceted evidence of respiratory inhibition. The promising results of the disease control efficacy in wheat heads infected with <italic toggle="yes">F. graminearum</italic> with the treatment of HK544 CF and EB<sub>1</sub> highlight their practical potential in crop protection against pathogenic fungi. Furthermore, the synergistic interactions between EB<sub>1</sub> and respiratory inhibitors, particularly complex I inhibitors, reveal novel opportunities for enhancing antifungal activity. Further research into the optimization of formulations and investigation of the activity spectrum could pave the way for the practical applications of HK544 containing EB<sub>1</sub> as an effective biofungicide in agriculture.</p></sec><sec sec-type="materials|methods" id="s4"><title>MATERIALS AND METHODS</title><sec id="s4-1"><title>Microbial strains and culture conditions</title><p>The soil-borne bacterium <italic toggle="yes">B. brevis</italic> HK544 strain was isolated from the soil at Daejeon, South Korea, and deposited as a patent microorganism to the Korean Agricultural Culture Collection (KACC, Jeonju, South Korea; No. KACC 81093BP). The bacterium was maintained on tryptic soy broth (TSB; BD Difco, San Jose, CA, USA) agar plate at 30&#x000b0;C. For the <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> antifungal activity, the <italic toggle="yes">F. graminearum</italic> wild-type strain Z-3639 was used as a target fungal pathogen and grown in complete medium (CM) or potato dextrose broth (PDB; BD Difco) supplemented with 1.5% agar as needed (<xref rid="B1" ref-type="bibr">1</xref>). Conidia from <italic toggle="yes">F. graminearum</italic> were induced in a carboxymethyl cellulose medium (<xref rid="B50" ref-type="bibr">50</xref>). A minimal medium including 5 mM agmatine (MMA) was used to evaluate trichothecene production (<xref rid="B51" ref-type="bibr">51</xref>). All microbial strains used in this study were stored in 20% glycerol at &#x02212;80&#x000b0;C.</p></sec><sec id="s4-2"><title>Mitochondrial respiratory inhibition assay</title><p>The inhibitory activity of mitochondrial respiration was investigated using the method described by Han et al. (<xref rid="B9" ref-type="bibr">9</xref>). Briefly, the growth inhibition of <italic toggle="yes">S. cerevisiae</italic> A-139 treated with CF or EB<sub>1</sub> was compared in two different media: YG (1% yeast extract and 2% glucose) and NFYG (1% yeast extract and 1% glycerol). After 24-h incubation, the optical density (OD<sub>600</sub>) of each well was measured using a microplate reader (Bio-rad, Hercules, CA, USA), and the growth inhibition (%) of the A-139 strain was calculated as follows: [1 &#x02212; (OD<sub>600</sub> of treatment/OD<sub>600</sub> of control)] &#x000d7; 100. The QoI fungicide kresoxim-methyl and 1% dimethyl sulfoxide (DMSO) were used as positive and negative controls, respectively.</p></sec><sec id="s4-3"><title>Measurement of ATP production</title><p>To measure the ATP production of <italic toggle="yes">F. graminearum</italic> treated with the HK544 CF, a conidial suspension (5 &#x000d7; 10<sup>7</sup> conidia/mL) was inoculated into 50 mL of PDB. After 24 h incubation, HK544 CF was added to the cultures at a final concentration of 0.1% and 1%, respectively. After 1- and 4-h incubation, mycelium was harvested and ground in liquid nitrogen with a pestle and mortar. ATP production in the ground mycelia was determined with the ATP Determination Kit (Invitrogen, Eugene, OR, USA) following the manufacturer&#x02019;s instructions. Fungal tissue (10 mg) was reacted with 1.25 &#x000b5;g/mL firefly luciferase, 50 &#x000b5;M D-luciferin, 1 mM dithiothreitol, and 1&#x000d7; reaction buffer. After a 15-min incubation, luminescence was measured by the BioTek Synergy LX multimode reader (Agilent Technologies).</p></sec><sec id="s4-4"><title>Isolation and identification of active compounds from HK544 CF</title><p>The HK544 strain was inoculated into 400 mL of TSB medium in a 2 L-Erlenmeyer flask and incubated at 25&#x000b0;C for 3 days with shaking (150 r/min). A total of 4 L of HK544 culture broth was centrifuged at 10,000 &#x000d7; <italic toggle="yes">g</italic> for 30 min and passed through Whatman No.1 filter paper (Maidstone, UK). The HK544 CF was applied onto a Diaion HP-20 column (5 &#x000d7; 30 cm; Mitsubishi Chemical, Tokyo, Japan) with a stepwise gradient elution of 0%, 20%, 40%, 60%, 80%, and 100% aqueous acetone to give F1&#x02013;F6. The 60% aqueous methanol fraction (2.0 g) exhibiting the antifungal activity was subjected to a reversed-phase flash column chromatography packed with LiChroprep RP-18 (40&#x02013;63 &#x000b5;m; Merck, Kenilworth, NJ, USA) and eluted with 0%, 20%, 40%, 60%, 80%, and 100% aqueous methanol (containing 0.1% formic acid). An active fraction F41 (200 mg) was further purified by a Sephadex LH 20 column (16 &#x000d7; 100 cm; Merck). The column was eluted at a flow rate of 0.1 mL/min with deionized water. Finally, the purified compound HKC1 (117 mg) was obtained and kept at &#x02212;20&#x000b0;C until further analysis.</p><p>The chemical structure of HKC1 was determined by spectroscopic analyses and comparisons with values in previous literature (<xref rid="B23" ref-type="bibr">23</xref>). The ESI-MS data were recorded on a single-quadruple mass spectrometer (Acquity QDa; Waters, Milford, MA, USA). All nuclear magnetic resonance (NMR) spectra were recorded in deuterium oxide (Cambridge Isotope Laboratories, Tewksbury, MA, USA) at 25&#x000b0;C on the Bruker Advance 500 MHz spectrometer (Bruker BioSpin, Rheinstetten, Germany).</p></sec><sec id="s4-5"><title><italic toggle="yes">In vitro</italic> antifungal activity assay</title><p>For the inhibitory effect of EB<sub>1</sub> on the conidial germination of <italic toggle="yes">F. graminearum</italic>, EB<sub>1</sub> dissolved in DMSO was added to the microplate wells containing a conidial suspension (5 &#x000d7; 10<sup>5</sup> conidia/mL of PDB). After a 10 h incubation at 25&#x000b0;C, the number of germinated conidia was counted by microscopic observation in 100 conidia. To investigate the mycelial growth inhibition of EB<sub>1</sub>, a mycelial disk (5 mm in diameter) of <italic toggle="yes">F. graminearum</italic> was inoculated onto CM supplemented with different concentrations of EB<sub>1</sub>, and then, the radial growth of <italic toggle="yes">F. graminearum</italic> was measured at 5 dpi. To determine the MIC values of CF and EB<sub>1</sub> against <italic toggle="yes">F. graminearum</italic>, we used the broth microdilution method as previously described (<xref rid="B52" ref-type="bibr">52</xref>). Briefly, a conidial suspension (1 &#x000d7; 10<sup>4</sup> conidia/mL of PDB) of <italic toggle="yes">F. graminearum</italic> was added to the wells of a 96-well microtiter plate, and then, EB<sub>1</sub> stock solutions dissolved in DMSO were added at an initial concentration of 25 &#x000b5;g/mL by twofold serial dilutions. The 1% DMSO was used for a negative control. After incubation for 24 h at 25&#x000b0;C, the MIC was determined by visual examination and corresponded to the lowest concentration that caused complete growth inhibition.</p></sec><sec id="s4-6"><title>Microscopic observation</title><p>The <italic toggle="yes">F. graminearum</italic> mycelia grown on CM containing the HK544 CF were observed under an FEI Quanta 250 FEG scanning electron microscope (Hillsboro, OR, USA) at 10 kV. To investigate the effect of EB<sub>1</sub> on <italic toggle="yes">F. graminearum</italic> membrane permeability, the conidia were incubated with EB<sub>1</sub> (12.5 &#x000b5;g/mL) for 4 h and then stained with 2 &#x000b5;M propidium iodide for 1 h. As a positive control, <italic toggle="yes">F. graminearum</italic> conidia was treated with 70% aqueous ethanol. Images were captured on an Olympus BS53 microscope (M&#x000fc;nster, Germany) with a filter set of 494 nm/515 nm (excitation/emission wavelength).</p></sec><sec id="s4-7"><title>Protein synthesis assay</title><p>To investigate the effects of EB<sub>1</sub> on protein synthesis in fungal cells, we evaluated the initial protein level using a Click-iT HPG Alexa Fluor 488 Protein Synthesis Assay kit (Thermo Fisher, Massachusetts, UK) according to the manufacturer&#x02019;s instructions. Briefly, a conidial suspension (1 &#x02009;&#x000d7;&#x02009; 10<sup>6</sup> conidia/mL of CM) of <italic toggle="yes">F. graminearum</italic> was treated with EB<sub>1</sub> (or cycloheximide) with 4 h incubation. After 1 h-additional incubation with HPG for 90 &#x02009;min, the fungal cells were fixed using a 3.7% formaldehyde solution and permeabilized with 0.5% Triton X-100 in PBS. The Click-iT reaction buffer containing Alexa Fluor dye with the azide moiety was added to the samples and then incubated for 30 min at room temperature in the dark. After washing with the Click-iT reaction rinse buffer, the samples were stained with 1&#x000d7; HCS NuclearMask blue stain solution, and the newly synthesized proteins were examined by an Olympus BS53 microscope (M&#x000fc;nster, Germany) with a consistent exposure time. For the quantification, the fluorescence signal intensity was determined using the BioTek Synergy LX multimode reader (Agilent Technologies).</p></sec><sec id="s4-8"><title>Transcriptome analysis</title><p>The <italic toggle="yes">F. graminearum</italic> Z-3639 strain was grown in 50 mL of CM at 25&#x000b0;C with shaking for 72 h and then incubated with EB<sub>1</sub> (10 &#x000b5;g/mL). After 1-, 2-, and 4-h incubation, the fungal mycelia were collected and washed twice with distilled water before being ground in liquid nitrogen. Total RNA was extracted with an Easy-Spin Total RNA Extraction Kit (iNtRON Biotechnology, Seongnam, South Korea) following the manufacturer&#x02019;s instructions, and RNA quality was assessed on the Agilent 2100 Bioanalyzer system (Agilent Technologies, Santa Clara, CA, USA). The total RNA was subjected to RNA-Seq library preparation using a TruSeq Stranded Total RNA Sample Prep Kit (Illumina, San Diego, CA, USA) following the manufacturer&#x02019;s instructions. Each library from three biological replicates per treatment (total 12 libraries) was sequenced for 101 bp paired-end reads with an Illumina NovaSeq6000 platform (Illumina) by Macrogen in Seoul, South Korea. The resulting sequences were analyzed using the Galaxy web-based platform. Trimming of reads was conducted using Trimmomatic (Galaxy version 0.38.1) (<xref rid="B53" ref-type="bibr">53</xref>), and the paired-end reads of each sample were aligned to the <italic toggle="yes">F. graminearum</italic> reference genome sequence using RNA STAR (Galaxy version 2.7.10b) (<xref rid="B54" ref-type="bibr">54</xref>). Gene expression quantification was computed using featureCounts (Galaxy version 2.0.3) (<xref rid="B55" ref-type="bibr">55</xref>), and the analysis of differential gene expression was performed using the DESeq2 R package (<xref rid="B56" ref-type="bibr">56</xref>). Enrichment analysis was performed in DAVID Bioinformatics Resources (<xref rid="B57" ref-type="bibr">57</xref>).</p></sec><sec id="s4-9"><title>Quantitative real-time PCR analysis</title><p>Total RNA was extracted using an Easy-Spin Total RNA Extraction Kit (iNtRON Biotechnology), and first-strand cDNA was synthesized from the total RNA using SuperScript III First-Strand Synthesis SuperMix (Invitrogen). qRT-PCR was performed using SsoFast EvaGreen Supermix (Bio-Rad) with the CFX Real-Time PCR System (Bio-Rad). An endogenous housekeeping gene <italic toggle="yes">ubh</italic> (FGSG_01231, ubiquitin C-terminal hydrolase) of <italic toggle="yes">F. graminearum</italic> was used as an internal control for normalization (<xref rid="B58" ref-type="bibr">58</xref>). Relative expression levels were calculated through the 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> method (<xref rid="B59" ref-type="bibr">59</xref>). The experiments were repeated twice, with three replicates for each. Primers used in the qRT-PCR are listed in Table S3.</p></sec><sec id="s4-10"><title>Generation of knockout strain</title><p>Gene knockout constructs were prepared by double-joint PCR as previously described (<xref rid="B60" ref-type="bibr">60</xref>). Briefly, the fungal genomic DNA of Z-3639 was extracted from freeze-dried mycelia powder according to the Fusarium laboratory manual (<xref rid="B1" ref-type="bibr">1</xref>). The 5&#x02032; and 3&#x02032; flanking regions (approximately 1.5 kb) of a target gene were amplified from <italic toggle="yes">F. graminearum</italic> gDNA and then were fused into a hygromycin resistance cassette (Hyg) amplified from pGEM-T_Hyg (<xref rid="B61" ref-type="bibr">61</xref>). The resulting constructs were transformed into the Z-3639 protoplasts using polyethylene glycol (PEG)-mediated transformation (<xref rid="B50" ref-type="bibr">50</xref>). Transformants grown on CM medium containing hygromycin were subjected to PCR-based screening using specific primer pairs. Primers used in the generation of knockout strains are listed in Table S3.</p></sec><sec id="s4-11"><title>EB<sub>1</sub>-induced haploinsufficiency analysis</title><p>DIH assay was performed by using <italic toggle="yes">S. pombe</italic> heterozygous deletion mutants from Bioneer (Daejeon, South Korea) based on the measurement of cell growth inhibition (<xref rid="B62" ref-type="bibr">62</xref>). Briefly, <italic toggle="yes">S. pombe</italic> cells were grown at 30&#x000b0;C in a complete YES medium containing 0.5% yeast extract, 2% glucose, and various supplements as described (<xref rid="B63" ref-type="bibr">63</xref>). The GI<sub>50</sub> value of EB<sub>1</sub> was determined against the <italic toggle="yes">S. pombe</italic> wild-type strain (SP286; h+/h+, ade6-M210/ade6-M216, ura4-D18/ura4-D18, leu1-32/leu1-32). Spore suspensions (1 &#x000d7; 10<sup>6</sup> cells/mL of YES medium) of a mitochondrial-related functional group subset, including 342 heterozygous deletion mutants of <italic toggle="yes">S. pombe</italic>, were added to the wells of a 96-well microtiter plate. Then, the EB<sub>1</sub> stock solution dissolved in DMSO was added at a final concentration of 80 &#x000b5;M. As a control, we used a YES medium containing 0.06% DMSO. The microtiter plates were incubated at 30&#x000b0;C for 20 h. The fitness value that represents the growth inhibitory potency of EB<sub>1</sub> at the GI<sub>50</sub> dose in each deletion mutant was calculated by dividing the cell mass (<italic toggle="yes">A</italic><sub>600</sub>) of the DMSO control with the one for the treated drug. Gene information on <italic toggle="yes">S. pombe</italic> was obtained from the PomBase database (<xref rid="B64" ref-type="bibr">64</xref>).</p></sec><sec id="s4-12"><title>FHB disease control efficacy</title><p>To investigate the disease control efficacy of HK544 CF and EB<sub>1</sub>, the spray inoculation method was used with wheat (<italic toggle="yes">Triticum aestivum</italic> cv. Eunpa) that was grown in a glasshouse at 25&#x000b0;C &#x000b1; 5&#x000b0;C for 4 weeks (<xref rid="B65" ref-type="bibr">65</xref>). Briefly, mid-anthesis stage wheat heads were sprayed with HK544 CF and EB<sub>1</sub> dissolved in sterile water using a hand-held atomizer; both samples contained 0.025% Tween 20 solution as a wetting agent. The sterile water alone served as a negative control. After the treated wheat plants were air dried for 24 h, 20 of each treated wheat head were sprayed with a conidial suspension (1 &#x000d7; 10<sup>6</sup> conidia/mL) of <italic toggle="yes">F. graminearum</italic> containing 0.025% Tween 20 solution. The inoculated plants were kept in the humidified chamber (25&#x000b0;C; 12 h photoperiod) for 3 days and then moved to a glasshouse at 25&#x000b0;C &#x000b1; 5&#x000b0;C. After 2 days of additional incubation, we recorded a percentage of the wheat head surface showing FHB symptoms. The FHB disease control efficacy was calculated with the following equation: control efficacy (%) = 100 &#x000d7; (1 &#x02212; <italic toggle="yes">B</italic>/<italic toggle="yes">A</italic>), where <italic toggle="yes">A</italic> is the mean of the lesion area (%) on the wheat head of the control plants and <italic toggle="yes">B</italic> is the mean of lesion area (%) on the wheat head of the treated plants (<xref rid="B65" ref-type="bibr">65</xref>).</p></sec><sec id="s4-13"><title>Trichothecene analysis</title><p>A conidial suspension (1 &#x000d7; 10<sup>6</sup> conidia/mL) was incubated in MMA medium supplemented with or without HK544 CF at 25&#x000b0;C under stationary growth conditions to measure trichothecene production. Trichothecenes were extracted from 7-day-old MMA cultures with an ethyl acetate-methanol mixture (4:1, vol/vol) as described previously (<xref rid="B49" ref-type="bibr">49</xref>). Briefly, the extracts were dried and derivatized with Sylon BTZ (Supelco, Bellefonte, PA, USA). Sequentially, the derivatized samples were mixed with an equal volume of n-hexane and distilled water. Then, the hexane layer was analyzed for trichothecene production using a Shimadzu QP2020 gas chromatograph-mass spectrometer (GC-MS) (Shimadzu, Kyoto, Japan). Quantification was performed by comparing the peak areas of the samples with those of external standards of DON and 15-ADON (Sigma-Aldrich, St. Louis, MO, USA), and then normalized by biomass.</p></sec><sec id="s4-14"><title>Synergetic effect assay</title><p>As previously described, a checkerboard assay was performed to determine synergism between EB<sub>1</sub> and respiratory inhibition compounds (<xref rid="B66" ref-type="bibr">66</xref>). Briefly, EB<sub>1</sub> and each inhibitor dissolved in DMSO were added using twofold serial dilutions in the x-axis and y-axis of a 96-well microtiter plate, respectively, containing an <italic toggle="yes">F. graminearum</italic> conidial suspension (1 &#x000d7; 10<sup>4</sup> conidia/mL). Rotenone (complex I), TTFA (complex II), antimycin A (complex III), and KCN (complex IV) were used as specific inhibitors for ETC complexes, and fenazaquin and fluopyram were used as chemical fungicides targeting complex I and II, respectively. As a negative control, we used a 1% DMSO treatment. After an 18 h incubation, the OD<sub>600</sub> value of each well was measured using a microplate reader (Bio-rad), and the growth inhibition (%) was calculated as follows: [1 &#x02212; (OD<sub>600</sub> of combined treatment/OD<sub>600</sub> of negative control)] &#x000d7; 100. Obtained data were analyzed with SynergyFinder (version 1.6.1), and the synergy score was evaluated based on the ZIP method (<xref rid="B67" ref-type="bibr">67</xref>, <xref rid="B68" ref-type="bibr">68</xref>). The results were interpreted by the ZIP scores as synergism, &#x0003e;10; indifference, &#x02212;10 &#x02013; 10; and antagonism, &#x0003c;&#x02212;10 (<xref rid="B68" ref-type="bibr">68</xref>).</p></sec><sec id="s4-15"><title>Statistical analysis</title><p>All experiments were repeated at least two times with three replicates each unless otherwise noted. Data were expressed as the mean &#x000b1; standard deviation. Statistical analysis was performed using R version 4.1.2 software. A two-tailed unpaired Student&#x02019;s <italic toggle="yes">t</italic>-test was used to compare the two groups. <italic toggle="yes">P</italic>-values less than 0.05 were considered statistically significant (*<italic toggle="yes">P</italic> &#x0003c; 0.05, **<italic toggle="yes">P</italic> &#x0003c; 0.01, ***<italic toggle="yes">P</italic> &#x0003c; 0.001). For FHB disease control efficacy, data were subjected to one-way ANOVA, and the means of the treatments were separated by Duncan&#x02019;s multiple range test (<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.05). Significant differences were indicated with different small letters in each bar.</p></sec></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>This work was supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) through Crop Viruses and Pests Response Industry Technology Development Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (No. 321101-03), and the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (NRF-2019R1A2C1008103).</p></ack><sec sec-type="data-availability" id="s5-1"><title>DATA AVAILABILITY</title><p>The transcriptome data sets were deposited in the National Center for Biotechnology Information Gene Expression Omnibus database with the accession number <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE214312" ext-link-type="uri">GSE214312</ext-link>.</p></sec><sec sec-type="supplementary-material" id="s5-2"><title>SUPPLEMENTAL MATERIAL</title><p specific-use="print-only">The following material is available online at <ext-link xlink:href="https://doi.org/10.1128/mbio.01351-24" ext-link-type="uri">https://doi.org/10.1128/mbio.01351-24</ext-link>.</p><supplementary-material id="SuF1" position="float" content-type="local-data"><object-id pub-id-type="doi">10.1128/mbio.01351-24.SuF1</object-id><label>Supplemental material</label><caption><title>mbio.01351-24-s0001.pdf</title><p>Fig. S1-S9, Tables S1-S3, and additional materials and methods.</p></caption><media xlink:href="mbio.01351-24-s0001.pdf"/></supplementary-material><p specific-use="online-only">ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse. </p></sec><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><string-name><surname>Leslie</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Summerell</surname>
<given-names>BA</given-names></string-name></person-group>. <year>2006</year>. <source>The Fusarium laboratory manual</source>. <publisher-name>Blackwell Publishing</publisher-name>, <publisher-loc>Ames, IA</publisher-loc>.</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Chen</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>MG</given-names></string-name></person-group>. <year>2009</year>. <article-title>Characterization of Fusarium graminearum isolates resistant to both carbendazim and a new fungicide Js399-19</article-title>. <source>Phytopathology</source>
<volume>99</volume>:<fpage>441</fpage>&#x02013;<lpage>446</lpage>. doi:<pub-id pub-id-type="doi">10.1094/PHYTO-99-4-0441</pub-id><pub-id pub-id-type="pmid">19271986</pub-id>
</mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Ma</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Michailides</surname>
<given-names>TJ</given-names></string-name></person-group>. <year>2005</year>. <article-title>Advances in understanding molecular mechanisms of fungicide resistance and molecular detection of resistant genotypes in phytopathogenic fungi</article-title>. <source>Crop Protection</source>
<volume>24</volume>:<fpage>853</fpage>&#x02013;<lpage>863</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cropro.2005.01.011</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Yin</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Miao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Shao</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>Z</given-names></string-name></person-group>. <year>2023</year>. <article-title>Fungicide resistance: progress in understanding mechanism, monitoring, and management</article-title>. <source>Phytopathology</source>
<volume>113</volume>:<fpage>707</fpage>&#x02013;<lpage>718</lpage>. doi:<pub-id pub-id-type="doi">10.1094/PHYTO-10-22-0370-KD</pub-id><pub-id pub-id-type="pmid">36624725</pub-id>
</mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Bartlett</surname>
<given-names>DW</given-names></string-name>, <string-name><surname>Clough</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Godwin</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Hall</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Hamer</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Parr&#x02010;Dobrzanski</surname>
<given-names>B</given-names></string-name></person-group>. <year>2002</year>. <article-title>The strobilurin fungicides</article-title>. <source>Pest Management Science</source>
<volume>58</volume>:<fpage>649</fpage>&#x02013;<lpage>662</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ps.520</pub-id><pub-id pub-id-type="pmid">12146165</pub-id>
</mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Shingu-Vazquez</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Traven</surname>
<given-names>A</given-names></string-name></person-group>. <year>2011</year>. <article-title>Mitochondria and fungal pathogenesis: drug tolerance, virulence, and potential for antifungal therapy</article-title>. <source>Eukaryot Cell</source>
<volume>10</volume>:<fpage>1376</fpage>&#x02013;<lpage>1383</lpage>. doi:<pub-id pub-id-type="doi">10.1128/EC.05184-11</pub-id><pub-id pub-id-type="pmid">21926328</pub-id>
</mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Duvenage</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Munro</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Gourlay</surname>
<given-names>CW</given-names></string-name></person-group>. <year>2019</year>. <article-title>The potential of respiration inhibition as a new approach to combat human fungal pathogens</article-title>. <source>Curr Genet</source>
<volume>65</volume>:<fpage>1347</fpage>&#x02013;<lpage>1353</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00294-019-01001-w</pub-id><pub-id pub-id-type="pmid">31172256</pub-id>
</mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Choi</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>HT</given-names></string-name>, <string-name><surname>Cho</surname>
<given-names>KY</given-names></string-name></person-group>. <year>2000</year>. <article-title>Efficient assay for respiration inhibitor using Saccharomyces cerevisiae</article-title>. <source>Korean J Pestic Sci</source>
<volume>4</volume>:<fpage>52</fpage>&#x02013;<lpage>59</lpage>.</mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Han</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Oh</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>H</given-names></string-name></person-group>. <year>2020</year>. <article-title>The antifungal test: an efficient screening tool for the discovery of microbial metabolites with respiratory inhibitory activity</article-title>. <source>Mycobiology</source>
<volume>48</volume>:<fpage>326</fpage>&#x02013;<lpage>329</lpage>. doi:<pub-id pub-id-type="doi">10.1080/12298093.2020.1766648</pub-id><pub-id pub-id-type="pmid">32952416</pub-id>
</mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>K&#x000f6;hl</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kolnaar</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Ravensberg</surname>
<given-names>WJ</given-names></string-name></person-group>. <year>2019</year>. <article-title>Mode of action of microbial biological control agents against plant diseases: relevance beyond efficacy</article-title>. <source>Front Plant Sci</source>
<volume>10</volume>:<elocation-id>845</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fpls.2019.00845</pub-id><pub-id pub-id-type="pmid">31379891</pub-id>
</mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Fravel</surname>
<given-names>DR</given-names></string-name></person-group>. <year>2005</year>. <article-title>Commercialization and implementation of biocontrol</article-title>. <source>Annu Rev Phytopathol</source>
<volume>43</volume>:<fpage>337</fpage>&#x02013;<lpage>359</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.phyto.43.032904.092924</pub-id><pub-id pub-id-type="pmid">16078888</pub-id>
</mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Fira</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Dimki&#x00107;</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Beri&#x00107;</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Lozo</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Stankovi&#x00107;</surname>
<given-names>S</given-names></string-name></person-group>. <year>2018</year>. <article-title>Biological control of plant pathogens by Bacillus species</article-title>. <source>J Biotechnol</source>
<volume>285</volume>:<fpage>44</fpage>&#x02013;<lpage>55</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jbiotec.2018.07.044</pub-id><pub-id pub-id-type="pmid">30172784</pub-id>
</mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Sunita</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Eunice</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Steve</surname>
<given-names>W</given-names></string-name></person-group>. <year>2010</year>. <article-title>Biological control of Fusarium oxysporum f. sp. Lycopersici on tomato by Brevibacillus brevis</article-title>. <source>J Phytopathol</source>
<volume>158</volume>:<fpage>470</fpage>&#x02013;<lpage>478</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1439-0434.2009.01635.x</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Yang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Yousef</surname>
<given-names>AE</given-names></string-name></person-group>. <year>2018</year>. <article-title>Antimicrobial peptides produced by Brevibacillus spp.: structure, classification and bioactivity: a mini review</article-title>. <source>World J Microbiol Biotechnol</source>
<volume>34</volume>:<fpage>57</fpage>. doi:<pub-id pub-id-type="doi">10.1007/s11274-018-2437-4</pub-id><pub-id pub-id-type="pmid">29594558</pub-id>
</mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Goswami</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Kistler</surname>
<given-names>HC</given-names></string-name></person-group>. <year>2004</year>. <article-title>Heading for disaster: Fusarium graminearum on cereal crops</article-title>. <source>Mol Plant Pathol</source>
<volume>5</volume>:<fpage>515</fpage>&#x02013;<lpage>525</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1364-3703.2004.00252.x</pub-id><pub-id pub-id-type="pmid">20565626</pub-id>
</mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Duan</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>M</given-names></string-name></person-group>. <year>2020</year>. <article-title>Quinone outside inhibitors affect DON biosynthesis, mitochondrial structure and toxisome formation in Fusarium graminearum</article-title>. <source>J Hazard Mater</source>
<volume>398</volume>:<fpage>122908</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jhazmat.2020.122908</pub-id><pub-id pub-id-type="pmid">32512449</pub-id>
</mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>de Chaves</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Reginatto</surname>
<given-names>P</given-names></string-name>, <string-name><surname>da Costa</surname>
<given-names>BS</given-names></string-name>, <string-name><surname>de Paschoal</surname>
<given-names>RI</given-names></string-name>, <string-name><surname>Teixeira</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Fuentefria</surname>
<given-names>AM</given-names></string-name></person-group>. <year>2022</year>. <article-title>Fungicide resistance in Fusarium graminearum species complex</article-title>. <source>Curr Microbiol</source>
<volume>79</volume>:<elocation-id>62</elocation-id>. doi:<pub-id pub-id-type="doi">10.1007/s00284-021-02759-4</pub-id><pub-id pub-id-type="pmid">34994875</pub-id>
</mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Legrand</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Picot</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Cobo-D&#x000ed;az</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Le Floch</surname>
<given-names>G</given-names></string-name></person-group>. <year>2017</year>. <article-title>Challenges facing the biological control strategies for the management of Fusarium head blight of cereals caused by F. graminearum</article-title>. <source>Biological Control</source>
<volume>113</volume>:<fpage>26</fpage>&#x02013;<lpage>38</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biocontrol.2017.06.011</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Veloukas</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Karaoglanidis</surname>
<given-names>GS</given-names></string-name></person-group>. <year>2012</year>. <article-title>Biological activity of the succinate dehydrogenase inhibitor fluopyram against Botrytis cinerea and fungal baseline sensitivity</article-title>. <source>Pest Manag Sci</source>
<volume>68</volume>:<fpage>858</fpage>&#x02013;<lpage>864</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ps.3241</pub-id><pub-id pub-id-type="pmid">22262495</pub-id>
</mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Kim</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>YS</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>H</given-names></string-name></person-group>. <year>2021</year>. <article-title>Genome sequence of Brevibacillus brevis HK544, an antimicrobial bacterium isolated from soil in Daejeon, South Korea</article-title>. <source>Microbiol Resour Announc</source>
<volume>10</volume>:<elocation-id>e0041721</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/MRA.00417-21</pub-id><pub-id pub-id-type="pmid">34351232</pub-id>
</mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Westman</surname>
<given-names>EL</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Waglechner</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Koteva</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Wright</surname>
<given-names>GD</given-names></string-name></person-group>. <year>2013</year>. <article-title>Self resistance to the atypical cationic antimicrobial peptide edeine of Brevibacillus brevis Vm4 by the N-acetyltransferase EdeQ</article-title>. <source>Chem Biol</source>
<volume>20</volume>:<fpage>983</fpage>&#x02013;<lpage>990</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chembiol.2013.06.010</pub-id><pub-id pub-id-type="pmid">23891151</pub-id>
</mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Duan</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Bian</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Long</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Du</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Dai</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>W</given-names></string-name></person-group>. <year>2022</year>. <article-title>Enhancement of edeine production in Brevibacillus brevis X23 via in situ promoter engineering</article-title>. <source>Microb Biotechnol</source>
<volume>15</volume>:<fpage>577</fpage>&#x02013;<lpage>589</lpage>. doi:<pub-id pub-id-type="doi">10.1111/1751-7915.13825</pub-id><pub-id pub-id-type="pmid">34310825</pub-id>
</mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Hettinger</surname>
<given-names>TP</given-names></string-name>, <string-name><surname>Craig</surname>
<given-names>LC</given-names></string-name></person-group>. <year>1970</year>. <article-title>Edeine. IV. structures of the antibiotic peptides edeines A<sub>1</sub> and B<sub>1</sub></article-title>. <source>Biochemistry</source>
<volume>9</volume>:<fpage>1224</fpage>&#x02013;<lpage>1232</lpage>. doi:<pub-id pub-id-type="doi">10.1021/bi00807a025</pub-id><pub-id pub-id-type="pmid">4984939</pub-id>
</mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Garreau de Loubresse</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Prokhorova</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Holtkamp</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Rodnina</surname>
<given-names>MV</given-names></string-name>, <string-name><surname>Yusupova</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Yusupov</surname>
<given-names>M</given-names></string-name></person-group>. <year>2014</year>. <article-title>Structural basis for the inhibition of the eukaryotic ribosome</article-title>. <source>Nature</source>
<volume>513</volume>:<fpage>517</fpage>&#x02013;<lpage>522</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature13737</pub-id><pub-id pub-id-type="pmid">25209664</pub-id>
</mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Polikanov</surname>
<given-names>YS</given-names></string-name>, <string-name><surname>Aleksashin</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Beckert</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Wilson</surname>
<given-names>DN</given-names></string-name></person-group>. <year>2018</year>. <article-title>The mechanisms of action of ribosome-targeting peptide antibiotics</article-title>. <source>Front Mol Biosci</source>
<volume>5</volume>:<elocation-id>48</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fmolb.2018.00048</pub-id><pub-id pub-id-type="pmid">29868608</pub-id>
</mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Lenaz</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Fato</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Formiggini</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Genova</surname>
<given-names>ML</given-names></string-name></person-group>. <year>2007</year>. <article-title>The role of coenzyme Q in mitochondrial electron transport</article-title>. <source>Mitochondrion</source>
<volume>7 Suppl</volume>:<fpage>S8</fpage>&#x02013;<lpage>33</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mito.2007.03.009</pub-id><pub-id pub-id-type="pmid">17485246</pub-id>
</mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Hekimi</surname>
<given-names>S</given-names></string-name></person-group>. <year>2016</year>. <article-title>Understanding ubiquinone</article-title>. <source>Trends Cell Biol</source>
<volume>26</volume>:<fpage>367</fpage>&#x02013;<lpage>378</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tcb.2015.12.007</pub-id><pub-id pub-id-type="pmid">26827090</pub-id>
</mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Torres</surname>
<given-names>NS</given-names></string-name>, <string-name><surname>Montelongo-Jauregui</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Abercrombie</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Srinivasan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lopez-Ribot</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Ramasubramanian</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Leung</surname>
<given-names>KP</given-names></string-name></person-group>. <year>2018</year>. <article-title>Antimicrobial and antibiofilm activity of synergistic combinations of a commercially available small compound library with colistin against Pseudomonas aeruginosa</article-title>. <source>Front Microbiol</source>
<volume>9</volume>:<elocation-id>2541</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2018.02541</pub-id><pub-id pub-id-type="pmid">30410476</pub-id>
</mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Chen</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Ruan</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Du</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Bian</surname>
<given-names>C</given-names></string-name></person-group>. <year>2023</year>. <article-title>The multifaceted roles of natural products in mitochondrial dysfunction</article-title>. <source>Front. Pharmacol</source>
<volume>14</volume>:<fpage>1093038</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fphar.2023.1093038</pub-id><pub-id pub-id-type="pmid">36860298</pub-id>
</mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Steinberg</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Gurr</surname>
<given-names>SJ</given-names></string-name></person-group>. <year>2020</year>. <article-title>Fungi, fungicide discovery and global food security</article-title>. <source>Fungal Genet Biol</source>
<volume>144</volume>:<elocation-id>103476</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.fgb.2020.103476</pub-id><pub-id pub-id-type="pmid">33053432</pub-id>
</mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Tamura</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Mizutani</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Yukioka</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Miki</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Ohba</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Masuko</surname>
<given-names>M</given-names></string-name></person-group>. <year>1999</year>. <article-title>Effect of the methoxyiminoacetamide fungicide, SSF129, on respiratory activity in Botrytis cinerea</article-title>. <source>Pestic. Sci</source>
<volume>55</volume>:<fpage>681</fpage>&#x02013;<lpage>686</lpage>. doi:<pub-id pub-id-type="doi">10.1002/(SICI)1096-9063(199907)55:7&#x0003c;681::AID-PS16&#x0003e;3.0.CO;2-8</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Mizutani</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Yukioka</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Tamura</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Miki</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Masuko</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Takeda</surname>
<given-names>R</given-names></string-name></person-group>. <year>1996</year>. <article-title>Respiratory characteristics in Pyricularia oryzae exposed to a novel alkoxyiminoacetamide fungicide</article-title> . <source>Phytopathology</source>
<volume>85</volume>:<fpage>306</fpage>. doi:<pub-id pub-id-type="doi">10.1094/Phyto-85-306</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Becker</surname>
<given-names>WF</given-names></string-name>, <string-name><surname>von Jagow</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Anke</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Steglich</surname>
<given-names>W</given-names></string-name></person-group>. <year>1981</year>. <article-title>Oudemansin, strobilurin A, strobilurin B and myxothiazol: new inhibitors of the bc1 segment of the respiratory chain with an E-&#x003b2;-methoxyacrylate system as common structural element</article-title>. <source>FEBS Lett</source>
<volume>132</volume>:<fpage>329</fpage>&#x02013;<lpage>333</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0014-5793(81)81190-8</pub-id><pub-id pub-id-type="pmid">6271595</pub-id>
</mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Desjardine</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Pereira</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Wright</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Matainaho</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kelly</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Andersen</surname>
<given-names>RJ</given-names></string-name></person-group>. <year>2007</year>. <article-title>Tauramamide, a lipopeptide antibiotic produced in culture by Brevibacillus laterosporus isolated from a marine habitat: structure elucidation and synthesis</article-title>. <source>J Nat Prod</source>
<volume>70</volume>:<fpage>1850</fpage>&#x02013;<lpage>1853</lpage>. doi:<pub-id pub-id-type="doi">10.1021/np070209r</pub-id><pub-id pub-id-type="pmid">18044840</pub-id>
</mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Barsby</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kelly</surname>
<given-names>MT</given-names></string-name>, <string-name><surname>Gagn&#x000e9;</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Andersen</surname>
<given-names>RJ</given-names></string-name></person-group>. <year>2001</year>. <article-title>Bogorol A produced in culture by a marine Bacillus sp. reveals a novel template for cationic peptide antibiotics</article-title>. <source>Org Lett</source>
<volume>3</volume>:<fpage>437</fpage>&#x02013;<lpage>440</lpage>. doi:<pub-id pub-id-type="doi">10.1021/ol006942q</pub-id><pub-id pub-id-type="pmid">11428033</pub-id>
</mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Singh</surname>
<given-names>PK</given-names></string-name><string-name><surname>Chittpurna</surname><given-names>A</given-names></string-name><string-name><surname>Sharma</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Patil</surname>
<given-names>PB</given-names></string-name>, <string-name><surname>Korpole</surname>
<given-names>S</given-names></string-name></person-group>. <year>2012</year>. <article-title>Identification, purification and characterization of laterosporulin, a novel bacteriocin produced by Brevibacillus sp. strain GI-9</article-title>. <source>PLoS ONE</source>
<volume>7</volume>:<elocation-id>e31498</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0031498</pub-id><pub-id pub-id-type="pmid">22403615</pub-id>
</mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>KURYLO-BOROWSKA</surname>
<given-names>Z</given-names></string-name></person-group>. <year>1959</year>. <article-title>Isolation and properties of pure edeine, an antibiotic of the strain Bacillus brevis Vm4</article-title>. <source>Biul Inst Med Morsk Gdansk</source>
<volume>10</volume>:<fpage>151</fpage>&#x02013;<lpage>163</lpage>.<pub-id pub-id-type="pmid">14412922</pub-id>
</mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Czajgucki</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Andruszkiewicz</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Kamysz</surname>
<given-names>W.</given-names></string-name></person-group>
<year>2006</year>. <article-title>Structure activity relationship studies on the antimicrobial activity of novel edeine A and D analogues</article-title>. <source>J Pept Sci</source>
<volume>12</volume>:<fpage>653</fpage>&#x02013;<lpage>662</lpage>.<pub-id pub-id-type="pmid">16847816</pub-id>
</mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Hill</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Bonjouklian</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Powis</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Abraham</surname>
<given-names>RT</given-names></string-name>, <string-name><surname>Ashendel</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Zalkow</surname>
<given-names>LH</given-names></string-name></person-group>. <year>1994</year>. <article-title>A Multisample assay for inhibitors of phosphatidylinositol phospholipase C: identification of naturally occurring peptide inhibitors with antiproliferative activity</article-title>. <source>Anticancer Drug Des</source>
<volume>9</volume>:<fpage>353</fpage>&#x02013;<lpage>361</lpage>.<pub-id pub-id-type="pmid">7916901</pub-id>
</mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Cozzarelli</surname>
<given-names>NR</given-names></string-name></person-group>. <year>1977</year>. <article-title>The mechanism of action of inhibitors of DNA synthesis</article-title>. <source>Annu Rev Biochem</source>
<volume>46</volume>:<fpage>641</fpage>&#x02013;<lpage>668</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.bi.46.070177.003233</pub-id><pub-id pub-id-type="pmid">143235</pub-id>
</mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Dinos</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Wilson</surname>
<given-names>DN</given-names></string-name>, <string-name><surname>Teraoka</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Szaflarski</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Fucini</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Kalpaxis</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Nierhaus</surname>
<given-names>KH</given-names></string-name></person-group>. <year>2004</year>. <article-title>Dissecting the ribosomal inhibition mechanisms of edeine and pactamycin: the universally conserved residues G693 and C795 regulate P-site RNA binding</article-title>. <source>Mol Cell</source>
<volume>13</volume>:<fpage>113</fpage>&#x02013;<lpage>124</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s1097-2765(04)00002-4</pub-id><pub-id pub-id-type="pmid">14731399</pub-id>
</mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Degli Esposti</surname>
<given-names>M</given-names></string-name></person-group>. <year>2014</year>. <article-title>Bioenergetic evolution in proteobacteria and mitochondria</article-title>. <source>Genome Biol Evol</source>
<volume>6</volume>:<fpage>3238</fpage>&#x02013;<lpage>3251</lpage>. doi:<pub-id pub-id-type="doi">10.1093/gbe/evu257</pub-id><pub-id pub-id-type="pmid">25432941</pub-id>
</mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Almeida</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Dhillon-LaBrooy</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Castro</surname>
<given-names>CN</given-names></string-name>, <string-name><surname>Adossa</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Carriche</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>Guderian</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lippens</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dennerlein</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hesse</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Lambrecht</surname>
<given-names>BN</given-names></string-name>, <string-name><surname>Berod</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Schauser</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Blazar</surname>
<given-names>BR</given-names></string-name>, <string-name><surname>Kalesse</surname>
<given-names>M</given-names></string-name>, <string-name><surname>M&#x000fc;ller</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Moita</surname>
<given-names>LF</given-names></string-name>, <string-name><surname>Sparwasser</surname>
<given-names>T</given-names></string-name></person-group>. <year>2021</year>. <article-title>Ribosome-targeting antibiotics impair T cell effector function and ameliorate autoimmunity by blocking mitochondrial protein synthesis</article-title>. <source>Immunity</source>
<volume>54</volume>:<fpage>68</fpage>&#x02013;<lpage>83</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2020.11.001</pub-id><pub-id pub-id-type="pmid">33238133</pub-id>
</mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Moullan</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Mouchiroud</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Ryu</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>EG</given-names></string-name>, <string-name><surname>Mottis</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Jovaisaite</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Frochaux</surname>
<given-names>MV</given-names></string-name>, <string-name><surname>Quiros</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>Deplancke</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Houtkooper</surname>
<given-names>RH</given-names></string-name>, <string-name><surname>Auwerx</surname>
<given-names>J</given-names></string-name></person-group>. <year>2015</year>. <article-title>Tetracyclines disturb mitochondrial function across eukaryotic models: a call for caution in biomedical research</article-title>. <source>Cell Rep</source>
<volume>10</volume>:<fpage>1681</fpage>&#x02013;<lpage>1691</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2015.02.034</pub-id><pub-id pub-id-type="pmid">25772356</pub-id>
</mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>He</surname>
<given-names>DC</given-names></string-name>, <string-name><surname>He</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Amalin</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Alvindia</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Zhan</surname>
<given-names>J</given-names></string-name></person-group>. <year>2021</year>. <article-title>Biological control of plant diseases: an evolutionary and eco-economic consideration</article-title>. <source>Pathogens</source>
<volume>10</volume>:<elocation-id>1311</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/pathogens10101311</pub-id><pub-id pub-id-type="pmid">34684260</pub-id>
</mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Kim</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ha</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>JI</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>NH</given-names></string-name>, <string-name><surname>Son</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>HW</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>CW</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>YW</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>JC</given-names></string-name></person-group>. <year>2017</year>. <article-title>Chemosensitization of Fusarium graminearum to chemical fungicides using cyclic lipopeptides produced by Bacillus amyloliquefaciens strain JCK-12</article-title>. <source>Front Plant Sci</source>
<volume>8</volume>:<elocation-id>2010</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fpls.2017.02010</pub-id><pub-id pub-id-type="pmid">29230232</pub-id>
</mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Stammler</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Speakman</surname>
<given-names>J</given-names></string-name></person-group>. <year>2006</year>. <article-title>Microtiter method to test the sensitivity of Botrytis cinerea to boscalid</article-title>. <source>J Phytopathol</source>
<volume>154</volume>:<fpage>508</fpage>&#x02013;<lpage>510</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1439-0434.2006.01139.x</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Myresiotis</surname>
<given-names>CK</given-names></string-name>, <string-name><surname>Bardas</surname>
<given-names>GA</given-names></string-name>, <string-name><surname>Karaoglanidis</surname>
<given-names>GS</given-names></string-name></person-group>. <year>2008</year>. <article-title>Baseline sensitivity of Botrytis cinerea to pyraclostrobin and boscalid and control of anilinopyrimidine-and benzimidazole-resistant strains by these fungicides</article-title>. <source>Plant Dis</source>
<volume>92</volume>:<fpage>1427</fpage>&#x02013;<lpage>1431</lpage>. doi:<pub-id pub-id-type="doi">10.1094/PDIS-92-10-1427</pub-id><pub-id pub-id-type="pmid">30769575</pub-id>
</mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Olaya</surname>
<given-names>G</given-names></string-name>, <string-name><surname>K&#x000f6;ller</surname>
<given-names>W</given-names></string-name></person-group>. <year>1999</year>. <article-title>Diversity of kresoxim-methyl sensitivities in baseline populations of Venturia inaequalis</article-title>. <source>Pestic Sci</source>
<volume>55</volume>:<fpage>1083</fpage>&#x02013;<lpage>1088</lpage>. doi:<pub-id pub-id-type="doi">10.1002/(SICI)1096-9063(199911)55:11&#x0003c;1083::AID-PS68&#x0003e;3.0.CO;2-U</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Oh</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Son</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>YW</given-names></string-name></person-group>. <year>2016</year>. <article-title>Transcription factor ART1 mediates starch hydrolysis and mycotoxin production in Fusarium graminearum and F. verticillioides</article-title>. <source>Mol Plant Pathol</source>
<volume>17</volume>:<fpage>755</fpage>&#x02013;<lpage>768</lpage>. doi:<pub-id pub-id-type="doi">10.1111/mpp.12328</pub-id><pub-id pub-id-type="pmid">26456718</pub-id>
</mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Gardiner</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Kazan</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Manners</surname>
<given-names>JM</given-names></string-name></person-group>. <year>2009</year>. <article-title>Nutrient profiling reveals potent inducers of trichothecene biosynthesis in Fusarium graminearum</article-title>. <source>Fungal Genetics and Biology</source>
<volume>46</volume>:<fpage>604</fpage>&#x02013;<lpage>613</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.fgb.2009.04.004</pub-id><pub-id pub-id-type="pmid">19406250</pub-id>
</mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Espinel-Ingroff</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Fothergill</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ghannoum</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Manavathu</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Ostrosky-Zeichner</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Pfaller</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rinaldi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Schell</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Walsh</surname>
<given-names>T</given-names></string-name></person-group>. <year>2005</year>. <article-title>Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole</article-title>. <source>J Clin Microbiol</source>
<volume>43</volume>:<fpage>5243</fpage>&#x02013;<lpage>5246</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JCM.43.10.5243-5246.2005</pub-id><pub-id pub-id-type="pmid">16207990</pub-id>
</mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Bolger</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Lohse</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Usadel</surname>
<given-names>B</given-names></string-name></person-group>. <year>2014</year>. <article-title>Trimmomatic: a flexible trimmer for Illumina sequence data</article-title>. <source>Bioinformatics</source>
<volume>30</volume>:<fpage>2114</fpage>&#x02013;<lpage>2120</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btu170</pub-id><pub-id pub-id-type="pmid">24695404</pub-id>
</mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Dobin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Davis</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Schlesinger</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Drenkow</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zaleski</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Jha</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Batut</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Chaisson</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gingeras</surname>
<given-names>TR</given-names></string-name></person-group>. <year>2013</year>. <article-title>STAR: ultrafast universal RNA-seq aligner</article-title>. <source>Bioinformatics</source>
<volume>29</volume>:<fpage>15</fpage>&#x02013;<lpage>21</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id>
</mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Liao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Smyth</surname>
<given-names>GK</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>W</given-names></string-name></person-group>. <year>2014</year>. <article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title>. <source>Bioinformatics</source>
<volume>30</volume>:<fpage>923</fpage>&#x02013;<lpage>930</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id><pub-id pub-id-type="pmid">24227677</pub-id>
</mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Love</surname>
<given-names>MI</given-names></string-name>, <string-name><surname>Huber</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Anders</surname>
<given-names>S</given-names></string-name></person-group>. <year>2014</year>. <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol</source>
<volume>15</volume>:<fpage>550</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id>
</mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Dennis</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Sherman</surname>
<given-names>BT</given-names></string-name>, <string-name><surname>Hosack</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Lane</surname>
<given-names>HC</given-names></string-name>, <string-name><surname>Lempicki</surname>
<given-names>RA</given-names></string-name></person-group>. <year>2003</year>. <article-title>DAVID: database for annotation, visualization, and integrated discovery</article-title>. <source>Genome Biol</source>
<volume>4</volume>:<fpage>1</fpage>&#x02013;<lpage>11</lpage>.</mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Kim</surname>
<given-names>HK</given-names></string-name>, <string-name><surname>Yun</surname>
<given-names>SH</given-names></string-name></person-group>. <year>2011</year>. <article-title>Evaluation of potential reference genes for quantitative RT-PCR analysis in Fusarium graminearum under different culture conditions</article-title>. <source>Plant Pathol</source>
<volume>27</volume>:<fpage>301</fpage>&#x02013;<lpage>309</lpage>. doi:<pub-id pub-id-type="doi">10.5423/PPJ.2011.27.4.301</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Livak</surname>
<given-names>KJ</given-names></string-name>, <string-name><surname>Schmittgen</surname>
<given-names>TD</given-names></string-name></person-group>. <year>2001</year>. <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>--&#x00394;&#x00394;CT</sup> method</article-title>. <source>Methods</source>
<volume>25</volume>:<fpage>402</fpage>&#x02013;<lpage>408</lpage>. doi:<pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id>
</mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Yu</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Hamari</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>KH</given-names></string-name>, <string-name><surname>Seo</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Reyes-Dom&#x000ed;nguez</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Scazzocchio</surname>
<given-names>C</given-names></string-name></person-group>. <year>2004</year>. <article-title>Double-joint PCR: a PCR-based molecular tool for gene manipulations in filamentous fungi</article-title>. <source>Fungal Genet Biol</source>
<volume>41</volume>:<fpage>973</fpage>&#x02013;<lpage>981</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.fgb.2004.08.001</pub-id><pub-id pub-id-type="pmid">15465386</pub-id>
</mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Han</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>DY</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>YR</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>SW</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>H</given-names></string-name></person-group>. <year>2020</year>. <article-title>Transcription factor PdeR is involved in fungal development, metabolic change, and pathogenesis of gray mold Botrytis cinerea</article-title>. <source>J Agric Food Chem</source>
<volume>68</volume>:<fpage>9171</fpage>&#x02013;<lpage>9179</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acs.jafc.0c02420</pub-id><pub-id pub-id-type="pmid">32786857</pub-id>
</mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Lee</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Yeon</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Roh</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Chae</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>HO</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>DM</given-names></string-name></person-group>. <year>2012</year>. <article-title>The natural anticancer agent plumbagin induces potent cytotoxicity in MCF-7 human breast cancer cells by inhibiting a PI-5 kinase for ROS generation</article-title>. <source>PLoS ONE</source>
<volume>7</volume>:<elocation-id>e45023</elocation-id>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0045023</pub-id><pub-id pub-id-type="pmid">23028742</pub-id>
</mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Kim</surname>
<given-names>DU</given-names></string-name>, <string-name><surname>Hayles</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Wood</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>HO</given-names></string-name>, <string-name><surname>Won</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Yoo</surname>
<given-names>HS</given-names></string-name>, <string-name><surname>Duhig</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Nam</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Palmer</surname>
<given-names>G</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2010</year>. <article-title>Analysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombe</article-title>. <source>Nat Biotechnol</source>
<volume>28</volume>:<fpage>617</fpage>&#x02013;<lpage>623</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nbt.1628</pub-id><pub-id pub-id-type="pmid">20473289</pub-id>
</mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Wood</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Harris</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>McDowall</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Rutherford</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Vaughan</surname>
<given-names>BW</given-names></string-name>, <string-name><surname>Staines</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Aslett</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lock</surname>
<given-names>A</given-names></string-name>, <string-name><surname>B&#x000e4;hler</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kersey</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>Oliver</surname>
<given-names>SG</given-names></string-name></person-group>. <year>2012</year>. <article-title>PomBase: a comprehensive online resource for fission yeast</article-title>. <source>Nucleic Acids Res</source>
<volume>40</volume>:<fpage>D695</fpage>&#x02013;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkr853</pub-id><pub-id pub-id-type="pmid">22039153</pub-id>
</mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Hu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Hamada</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Dawood</surname>
<given-names>DH</given-names></string-name>, <string-name><surname>Zheng</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>Z</given-names></string-name></person-group>. <year>2014</year>. <article-title>Potential of Pseudomonas chlororaphis subsp. aurantiaca strain Pcho10 as a biocontrol agent against Fusarium graminearum</article-title>. <source>Phytopathology</source>
<volume>104</volume>:<fpage>1289</fpage>&#x02013;<lpage>1297</lpage>. doi:<pub-id pub-id-type="doi">10.1094/PHYTO-02-14-0049-R</pub-id><pub-id pub-id-type="pmid">24941327</pub-id>
</mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Caleffi-Ferracioli</surname>
<given-names>KR</given-names></string-name>, <string-name><surname>Maltempe</surname>
<given-names>FG</given-names></string-name>, <string-name><surname>Siqueira</surname>
<given-names>VLD</given-names></string-name>, <string-name><surname>Cardoso</surname>
<given-names>RF</given-names></string-name></person-group>. <year>2013</year>. <article-title>Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method</article-title>. <source>Tuberculosis (Edinb)</source>
<volume>93</volume>:<fpage>660</fpage>&#x02013;<lpage>663</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tube.2013.09.001</pub-id><pub-id pub-id-type="pmid">24083948</pub-id>
</mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Ianevski</surname>
<given-names>A</given-names></string-name>, <string-name><surname>He</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Aittokallio</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>J</given-names></string-name></person-group>. <year>2017</year>. <article-title>SynergyFinder: a web application for analyzing drug combination dose&#x02013;response matrix data</article-title>. <source>Bioinformatics</source>
<volume>33</volume>:<fpage>2413</fpage>&#x02013;<lpage>2415</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btx162</pub-id><pub-id pub-id-type="pmid">28379339</pub-id>
</mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Yadav</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Wennerberg</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Aittokallio</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>J</given-names></string-name></person-group>. <year>2015</year>. <article-title>Searching for drug synergy in complex dose&#x02013;response landscapes using an interaction potency model</article-title>. <source>Comput Struct Biotechnol J</source>
<volume>13</volume>:<fpage>504</fpage>&#x02013;<lpage>513</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.csbj.2015.09.001</pub-id><pub-id pub-id-type="pmid">26949479</pub-id>
</mixed-citation></ref></ref-list></back></article>